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[Intervention Review]
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ABSTRACT
Background
Topical local anaesthetics provide effective analgesia for patients undergoing numerous superficial procedures, including repair of dermal
lacerations. The need for cocaine in topical anaesthetic formulations has been questioned because of concern about adverse effects,
thus novel preparations of cocaine-free anaesthetics have been developed. This review was originally published in 2011 and has been
updated in 2017.
Objectives
To assess whether benefits of non-invasive topical anaesthetic application occur at the expense of decreased analgesic efficacy. To compare
the efficacy of various single-component or multi-component topical anaesthetic agents for repair of dermal lacerations. To determine
the clinical necessity for topical application of the ester anaesthetic, cocaine.
Search methods
For this updated review, we searched the following databases: Cochrane Central Register of Controlled Trials (CENTRAL; 2016, Issue
11), Cumulative Index to Nursing and Allied Health Literature (CINAHL; 2010 to December 2016), Embase (2010 to December
2016) and MEDLINE (2010 to December 2016). We did not limit this search by language or format of publication. We contacted
manufacturers, international scientific societies and researchers in the field. Weemailed selected journalsand reviewed meta-registers of
ongoing trials. For the previous version of this review, we searched these databases to November 2010.
Selection criteria
We included randomized controlled trials (RCTs) that evaluated the efficacy and safety of topical anaesthetics for repair of dermal
laceration in adult and paediatric participants.
Topical anaesthetics for pain control during repair of dermal laceration (Review)
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Data collection and analysis
Two review authors independently assessed trial quality and extracted data. We contacted study authors for additional information
when needed. We collected adverse event information from trial reports. We assessed methodological risk of bias for each included
study and employed the GRADE approach to assess the overall quality of the evidence.
Main results
The present updated review included 25 RCTs involving 3278 participants. The small number of trials in each comparison group and
the heterogeneity of outcome measures precluded quantitative analysis of data for all but one outcome: pain intensity. In two pooled
studies, the mean self-reported visual analogue scale (VAS; 0 to 100 mm) score for topical prilocaine-phenylephrine (PP) was higher
than the mean self-reported VAS (0 to 100 mm) score for topical tetracaine-epinephrine-cocaine (TAC) by 5.59 points (95% confidence
interval (CI) 2.16 to 13.35). Most trials that compared infiltrated and topical anaesthetics were at high risk of bias, which is likely to
have affected their results. Researchers found that several cocaine-free topical anaesthetics provided effective analgesic efficacy. However,
data regarding the efficacy of each topical agent are based mostly on single comparisons in trials with unclear or high risk of bias. Mild,
self-limited erythematous skin induration occurred in one of 1042 participants who had undergone application of TAC. Investigators
reported no serious complications among any of the participants treated with cocaine-based or cocaine-free topical anaesthetics. The
overall quality of the evidence according to the GRADE system is low owing to limitations in design and implementation, imprecision
of results and high probability of publication bias (selective reporting of data). Additional well-designed RCTs with low risk of bias are
necessary before definitive conclusions can be reached.
Authors’ conclusions
We have found two new studies published since the last version of this review was prepared. We have added these studies to those
previously included and have conducted an updated analysis, which resulted in the same review conclusions as were presented previously.
Mostly descriptive analysis indicates that topical anaesthetics may offer an efficacious, non-invasive means of providing analgesia before
suturing of dermal lacerations. Use of cocaine-based topical anaesthetics might be hard to justify, given the availability of other effective
topical anaesthetics without cocaine. However, the overall quality of the evidence according to the GRADE system is low owing to
limitations in design and implementation, imprecision of results and high probability of publication bias (selective reporting of data).
Additional well-designed RCTs with low risk of bias are necessary before definitive conclusions can be reached.

PLAIN LANGUAGE SUMMARY
Local anaesthesia (numbing medicine) that is directly applied to the skin can provide pain control for repair of skin lacerations
Background: Pain control during suturing of torn skin is generally achieved by injecting medication into the skin (infiltration) to numb
the area. This injection itself may cause pain, but topical anaesthetics are applied directly to the skin and are painless to administer.
Cocaine was one of the first anaesthetics to be successfully applied topically. Concerns over adverse effects of cocaine, its potential
misuse and the administrative burden of dispensing a controlled substance led to the development of cocaine-free topical anaesthetics.
Multiple cocaine-free topical anaesthetics have been found to provide effective anaesthesia for repair of dermal lacerations.
Study characteristics: The evidence is current to December 2016. We included in this review 25 randomized controlled trials involving
3278 participants. Studies included both adults and children. Fifteen of the included trials used self-reporting of pain intensity by trial
participants to determine the effectiveness of local anaesthetics.
Key results: Study results suggest that directly applying local anaesthetics to the skin is an effective, non-invasive way of providing pain
control during suturing or stapling of skin lacerations. Study findings on the efficacy of individual topical anaesthetics were limited by
study design, and data on the efficacy of each topical agent were obtained mostly from single trials. Researchers reported no serious
side effects following the use of cocaine-containing or cocaine-free topical anaesthetics. The overall broadly comparable effectiveness
of cocaine-free topical anaesthetics for skin laceration repair brings into question the necessity to include cocaine as a component of
local anaesthetic solutions. The small number of trials in each comparison group and the range of outcome measures assessed prevented
pooling and quantitative analysis of data for all but the single outcome of pain intensity.
Additional studies are necessary to directly compare the effectiveness of different formulations of topical anaesthetics. Our review was
limited to pain control for repair of superficial lacerations, and our results might not be generalizable to deeper lacerations or more
Topical anaesthetics for pain control during repair of dermal laceration (Review)
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complex procedures performed on intact skin. Further research is needed to strengthen the evidence and to overcome the weakness of
the included studies.
Quality of the evidence: The overall quality of the evidence was low owing to limitations in study design, ways that studies were carried
out (implementation), imprecision of results and high probability of selective data reporting. Most of the trials that compared infiltrated
and topical anaesthetics were at high risk of bias, and this was likely to influence measured effects.

Topical anaesthetics for pain control during repair of dermal laceration (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

3

Topical anaesthetics for pain control during repair of dermal laceration (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]

Pain control using topical local anaesthetics com pared with inf iltrated local anaesthetics or other topical agents f or pain control during repair of derm al lacerations
Patient or population: adults and paediatric patients with derm al laceration
Settings: any m edical setting
Intervention: topical local anaesthetics f or pain control during repair of derm al laceration
Comparison: inf iltrated local anaesthetics or other topical agents f or pain control during repair of derm al lacerations
Outcomes

Illustrative comparative risks* (95% CI)

Assumed risk

Relative effect
(95% CI)

Number of participants Quality of the evidence Comments
(studies)
(GRADE)

Corresponding risk

(Infiltrated
local (Topical local anaesanaesthetics or other thetics)
topical agents)

4

Pain intensity m ea- See com m ent
sures
Cocaine- containing
topical anaesthetics vs
infiltrated local anaesthetics

See com m ent

Not estim able

1006
(6 studies)

⊕⊕
Lowa

Unable to m athem atically com bine results
because of heterogeneity of outcom e m easures

Pain intensity m ea- See com m ent
sures
Comparisons between
different cocaine- containing topical anaesthetics

See com m ent

Not estim able

530
(4 studies)

⊕⊕
Lowb

Unable to m athem atically com bine results
because each topical
anaesthetic com parison was lim ited to a single study

Pain intensity m ea- See com m ent
sures
Cocainefree topical anaesthetics compared with infiltrated local anaesthet-

See com m ent

Not estim able

543
(6 studies)

⊕⊕
Lowc

Unable to m athem atically com bine results
because of heterogeneity of outcom e m easures
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ics
Pain intensity m ea- See com m ent
sures
Cocainefee topical anaesthetics compared with cocaine- containing topical anaesthetics

See com m ent

Not estim able

1231
(11 studies)

⊕⊕
Lowd

Two of the 11 trials studied a com m on
topical anaesthetic and
could be m athem atically com bined

Pain intensity m ea- See com m ent
sures
Comparisons between
different cocaine- free
topical anaesthetics

See com m ent

Not estim able

656
(5 studies)

⊕⊕
Lowe

Trials could not be
m athem atically com bined because each
study com pared a dif f erent cocaine-f ree topical anaesthetic

RR 0
(0 to 0)

1686
(11 studies)

Anaesthetic- related
adverse effects

Study population
1 per 1000

0 per 1000
(0 to 0)

M edium- risk population
* The basis f or the assumed risk (e.g. m edian control group risk across studies) is provided in f ootnotes. The corresponding risk (and its 95% conf idence interval) is based on
assum ed risk in the com parison group and the relative effect of the intervention (and its 95% CI).
CI: conf idence interval; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: Further research is very unlikely to change our conf idence in the estim ate of ef f ect.
M oderate quality: Further research is likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and m ay change the estim ate.
Low quality: Further research is very likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and is likely to change the estim ate.
Very low quality: We are very uncertain about the estim ate.
a Each

of the trials had high risk of bias in m ultiple dom ains or unclear risk of bias in three dom ains.
of the f our trials had at least one dom ain that was at high risk of bias.
c
Two of the trials had unclear risk of bias in m ultiple dom ains, and the other two studies had high risk of bias in two dom ains.

b Two
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d Six

of the studies had high risk of bias f or at least one dom ain, and the other f ive studies had unclear risk of bias f or one or
m ore dom ains.
e Each of the f ive trials had unclear risk of bias in one or m ore dom ains. However, no trials contained any dom ains that were
clearly at high risk
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BACKGROUND
Local anaesthetic efficacy (capacity for producing desired anaesthetic effect) during procedures such as wound repair is assessed
by the patient’s self-report of pain intensity during the intervention. Acceptable tools for quantifying pain intensity include the
visual analogue scale (VAS), the numerical rating scale, the verbal
rating scale, the Faces scale and other validated descriptors of pain
intensity or relief. Studies have shown non-concordance between
participants’ and practitioners’ assessments of procedure-related
pain intensity (Benzon 2011; Castarlenas 2016; Choiniere 1990;
Hjermstad 2011; Singer 1999; Stephenson 1994).

Description of the condition
Pain caused by repair of torn skin may be an unpleasant experience
for patients. Analgesia or pain control is conventionally achieved
through local anaesthetic infiltration. Local anaesthetics make up a
class of drugs that interrupt the transmission of electrical impulses
along sensory nerves by inactivating sodium channels (Stoelting
1999). However, infiltration of local anaesthetics, which involves
injecting medication into the skin, may itself cause significant pain
(Kundu 2002). Many patients, especially children, fear or dislike
needles. Topical anaesthetics are not injected. Rather, agents are
directly applied to a local area of the skin. Therefore, topical anaesthesia may be preferable to infiltration anaesthesia for pain control during skin laceration repair. Topical anaesthetics are available
in several forms, including solutions, gels, creams, ointments and
skin patches. Adverse reactions to topical local anaesthetics include
local responses (rash, stinging) and systemic allergic reactions (diffuse swelling, difficulty breathing, anaphylaxis) (Drug Facts and
Comparisons 2015). An overdose of topical local anaesthetics may
adversely affect the cardiovascular or central nervous system (Drug
Facts and Comparisons 2015). Untoward effects resulting from
high systemic levels of local anaesthetics include hypotension, cardiac arrhythmias (bradycardia, ventricular fibrillation, asystole),
light-headedness, double vision, a metallic taste, drowsiness and
seizures (Stoelting 1999).
In 1980, Pryor et al published the first report on successful
use of topical anaesthesia for repair of torn skin (Pryor 1980).
The initial formulation, tetracaine-adrenaline-cocaine (TAC),
gained widespread acceptance in North America and has largely
supplanted infiltration anaesthesia for this purpose (the term
’epinephrine’ rather than ’adrenaline’ is used in the USA) (Grant
1992). However, the necessity to include cocaine in topical anaesthetic formulations has been questioned owing to concern over
possible adverse effects (Bush 2002; Grant 1992). Although application of TAC to skin lacerations results in undetectable or low
systemic cocaine levels (Terndrup 1992; Vinci 1999), inadvertent
mucosal application or overdose may cause significant cocaine absorption, resulting in serious consequences such as seizures (Dailey

1988; Daya 1988; Tipton 1988; Wehner 1984). Moreover, administrative and financial burdens accompany dispensing of a controlled substance that is widely abused in the community. Accordingly, over the past decade, novel preparations of cocaine-free topical anaesthetics have been developed. Analysis of the efficacy and
safety of established and recently developed topical anaesthetics is
needed.
Pain caused by repair of dermal lacerations may be an unpleasant
experience for patients. Analgesia or pain control is conventionally achieved through local anaesthetic infiltration (i.e. injection).
However, injection of local anaesthetics into the skin may itself
cause significant pain (Kundu 2002). Many patients, especially
children, fear or dislike needles. Topical anaesthetics are not injected. Rather, agents are directly applied to the locally traumatized area or to adjoining skin. Therefore, topical anaesthesia may
be preferable to infiltration anaesthesia for pain control during
skin laceration repair.

Description of the intervention
Repair of superficial dermal laceration is usually a minor procedure that is done in an outpatient setting. Wound repair could be
done with surgical sutures or by non-invasive approaches such as
skin adhesive or glue; in any case, pain control is required. Traditionally, this is accomplished by infiltrating the wound with local
anaesthetics, possibly supplemented with systemic analgesia or sedation.
Local anaesthetics constitute a class of drugs that interrupt the
transmission of electrical impulses along nerves by inactivating
sodium channels (Brunton 2011; Stoelting 1999). Adverse reactions to topical local anaesthetics include local responses (rash,
stinging) and systemic allergic reactions (diffuse swelling, difficulty breathing, anaphylaxis) (Dickerson 2014; Drug Facts and
Comparisons 2015). An overdose of topical local anaesthetics may
adversely affect the cardiovascular or central nervous system (Drug
Facts and Comparisons 2015). Untoward effects from high systemic levels of local anaesthetics include hypotension, cardiac arrhythmias (bradycardia, ventricular fibrillation, asystole), lightheadedness, double vision, a metallic taste, drowsiness and seizures
(Brunton 2011; Stoelting 1999).
Tradiltionally, local anaesthetics were injected locally, but recently,
newer preparations have allowed local anaesthetics to be applied
topically without the discomfort or anxiety that frequently accompanies needle injections. We aimed to compare the application of
topical anaesthetics versus traditional infiltration for pain control
during wound repair.
We included in this review only trials that evaluated the efficacy
of topical local anaesthetics for repair of dermal (skin) lacerations.
We included comparisons between:
1. infiltrated local anaesthetic agents and topically applied local
anaesthetic agents; and
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2. various topical local anaesthetic formulations versus a control
formulation.

How the intervention might work
Local anaesthetics make up a class of drugs that interrupt the transmission of electrical impulses along nerves by inactivating sodium
channels (Brunton 2011; Stoelting 1999). Topical anaesthetics
are available in several different forms, including solutions, gels,
creams, ointments and skin patches.

Why it is important to do this review
In 1980, Pryor et al published the first report of successful use
of topical anaesthesia for repair of torn skin (Pryor 1980). The
initial formulation, tetracaine-adrenaline-cocaine (TAC), gained
widespread acceptance in North America, largely supplanting infiltration anaesthesia for this purpose (the word ’epinephrine’ rather
than ’adrenaline’ is used in the USA) (Grant 1992). However, the
necessity to include cocaine in topical anaesthetic formulations
has been questioned owing to concern over possible adverse effects (Bush 2002; Grant 1992). Although application of TAC to
skin lacerations results in undetectable or low systemic cocaine
levels (Terndrup 1992; Vinci 1999), inadvertent mucosal application or overdose may cause significant cocaine absorption, resulting in serious consequences such as seizures (Dailey 1988; Daya
1988; Tipton 1988; Wehner 1984). Moreover, administrative and
financial burdens accompany dispensing of a controlled substance
that is widely abused in the community. Accordingly, novel preparations of cocaine-free topical anaesthetics have been developed.
Analysis of the efficacy and safety of established and recently developed topical anaesthetics is needed.

OBJECTIVES
To assess whether benefits of non-invasive topical anaesthetic application occur at the expense of decreased analgesic efficacy. To
compare the efficacy of various single-component or multi-component topical anaesthetic agents for repair of dermal lacerations.
To determine the clinical necessity for topical application of the
ester anaesthetic, cocaine.

Types of studies
We included only randomized controlled trials (RCTs) and quasirandomized trials. Blinding was not an exclusion criterion. We
included relevant trials that were published in abstract format or
were presented at national or international society meetings. We
attempted to locate unpublished studies by contacting relevant
manufacturers and investigators. We did not consider data from
review articles, case reports or letters to the editor.
Types of participants
We included adult and paediatric participants of either sex. We
did not set a minimum age threshold so that we could identify as
many relevant studies as possible.
Types of interventions
We included only trials that evaluated the efficacy of topical local
anaesthetics for pain control during repair of dermal (skin) lacerations. We included comparisons between:
1. infiltrated local anaesthetic agents and topically applied
local anaesthetic agents; and
2. different topical local anaesthetic formulations.
We defined topical anaesthetics as agents that are directly applied
to the skin to produce numbness. We included both amide and
ester local anaesthetics. We accepted topical preparations that contain more than one local anaesthetic. We also included multi-component topical anaesthetics that contain vasoconstrictors (i.e. cocaine, adrenaline). Acceptable formulations of topical local anaesthetics have included solution, gel, cream, ointment, lotion, jelly,
balm, and aerosol spray. We excluded studies that administered
local anaesthetics via iontophoresis (a mild electrical current).
We excluded studies in which investigators applied topical anaesthetics to mucous membranes (moist linings of the mouth, nose
and eyes). To ensure that procedures evaluated involved approximately equivalent intensity and quality of pain, we limited the
technique of skin closure to instrumentation involving suture
placement or stapling. We excluded studies that examined less invasive approaches to repair of lacerations, such as application of
tape or tissue adhesives. We included only studies in which participants had superficial injuries involving the epidermis or dermal
layers. We did not consider deeper wounds involving the fascia or
non-skin structures. We set no limitations on the dimensions of
the laceration, but we excluded procedures on infected wounds.
We excluded studies in which study personnel administered systemic analgesics or sedatives that may influence the participants’
perceived or reported pain intensity.

METHODS
Types of outcome measures

Criteria for considering studies for this review

Both primary and secondary outcomes are the same as those described in the 2011 review (Eidelman 2011); we have slightly
rewritten them to improve clarity.

Topical anaesthetics for pain control during repair of dermal laceration (Review)
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Primary outcomes

Searching other resources

Our primary outcome was participant-reported pain intensity during wound repair. We included any type of pain intensity scale that
was described clearly by study authors. Although we attempted
to apply statistical methods to normalize the data and perform a
meta-analysis, we could not do this because of the small number
of trials in each comparison group and their heterogeneous outcomes.

We manually searched the following journals (1980 through
2009), or we searched them electronically (by searching via different search engines and/or inquiring by email to the appropriate
department of a journal publisher (2010 through 2015)).
1. Academic Emergency Medicine.
2. Annals of Emergency Medicine.
3. Emergency Medicine Clinics of North America.
4. Journal of Emergency Medicine.
5. Emergency Medicine Australasia (formerly known as
Emergency Medicine).
6. Elsevier B.V. (email inquiry 2015).
We reviewed abstracts presented at the following national or international society meetings (before 2010), and in 2015, we emailed
the following societies to ask about relevant new abstracts.
1. American Academy of Pain Medicine (AAPM).
2. American Pain Society (APS).
3. American College of Emergency Physicians (ACEP).
4. American Society of Anesthesiologists (ASA).
5. American Society of Regional Anesthesia and Pain
Medicine (ASRA).
6. European Society of Regional Anaesthesia and Pain
Therapy (ESRA).
7. Society for Academic Emergency Medicine (SAEM).
We contacted the following manufacturers of topical anaesthetics
to inquire about ongoing or unpublished trials.
1. AstraZeneca.
2. Endo Pharmaceuticals.
3. Ferndale Laboratories.
4. New England Compounding Center.
5. Smith & Nephew.
6. Topicaine.NET.
7. Novocol.
8. Henry Schein, Inc.
9. Ferndale Pharma Group, Inc.
We contacted study authors and searched articles from the reference lists of retrieved articles. We also searched the US National
Institutes of Health electronic website (ClinicalTrials.gov).

Secondary outcomes

1. Indirect predictors of pain intensity during wound repair,
including incidence of topical anaesthetic failure necessitating
systemic sedation or analgesia; requirement for supplemental
local anaesthetic dosing; participants’ acceptance of anaesthesia;
participants’ behavioural responses; and observer (clinician or
family) assessment of pain intensity during wound repair.
2. Topical anaesthesia-related acute toxicity (reported shortly
after application, e.g. neurological and cardiovascular toxicity)
and other adverse effects (e.g. allergic reaction).

Search methods for identification of studies

Electronic searches
For this updated review, we searched the following databases:
Cochrane Central Register of Controlled Trials (CENTRAL;
2016, Issue 11), Cumulative Index to Nursing and Allied Health
Literature (CINAHL; 2010 to December 2016), Embase (2010
to December 2016) and MEDLINE (2010 to December 2016).
We did not limit our search by language or format of publication.
We contacted manufacturers, scientific societies and researchers in
the field. (For the previously published version of this review, we
searched to November 2010 (Eidelman 2011).)
We sought unpublished studies by directly contacting primary
investigators for the included trials. We searched for additional
papers by reviewing the references of each retrieved study.
We searched MEDLINE, CENTRAL and CINAHL by using the
search strategy described in Appendix 1, Appendix 2 and Appendix
3. We combined the MEDLINE search with the first two levels of
the optimal trial search (Higgins 2011). We searched Embase by
using the search strategy found in Appendix 4.
We searched meta-registers of ongoing trials (http://
www.controlled-trials.com/; clinicaltrials.gov). We identified one
ongoing study (Ridderikhof 2015) but excluded it because it did
not meet our inclusion criteria: It was not an RCT but rather was
an observational case series. We identified no studies awaiting classification.
We limited included trials to human studies. We applied no language restrictions during the literature search.

Data collection and analysis
Selection of studies
Two review authors (BT and CE, AE, DC or EM) independently
reviewed study titles and abstracts identified by the search strategy.
We obtained the full publication if at least one review author decided that the study potentially met inclusion criteria. Two review
authors (BT and AE, CE or EM) independently examined the full
articles retrieved and selected trials that met the inclusion criteria.
In the event of disagreement, we consulted another review author
(DC).
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Data extraction and management

Unit of analysis issues

For the latest version of this review, two review authors independently extracted data using the uniform data extraction sheet
(Appendix 5). We compared information retrieved by each pair of
review authors to verify accuracy, and we resolved disagreements
by consensus.
For this update, we have identified two new articles that met the
inclusion criteria (Jenkins 2014; Lee 2013); both provided descriptive data. We updated the data collection form (Appendix 5)
so it reflects interim changes in assessment of selective reporting
and sample size biases. Two review authors (BT and AE, CE, DC
or EM) independently extracted data from each article and reextracted data from previously included articles to assess selective
reporting and potential bias as judged from sample size. In cases
of disagreement, we consulted a third review author to resolve the
issue.

All included trials included parallel arms with different interventions. Investigators randomized participants to one of the arms
and reported and analysed results for each individual. We identified no issues with double assignment or reporting.

Assessment of risk of bias in included studies
Two review authors independently assessed each study for risk of
bias. In cases of disagreement, we consulted a third review author.
We applied the Higgins 2001 (Version 5.1.0, Chapter 8) ’Risk of
bias’ tool to both earlier and newly included studies. In addition,
we included the sample size risk of bias: We considered studies
with 200 or more participants per group to be at low risk, studies
with 50 to 200 participants per group to have unknown risk and
studies with fewer than 50 participants to be at high risk (Mcnicol
2015).

Dealing with missing data
For prior updates, if necessary, we sent email or a letter by postal
mail to the contact author to request missing information. We
sought additional data from eight trials, but we were able to
successfully obtain additional information from only one study
(Smith 1997a). Furthermore, we contacted by email and received
responses from two primary authors - Drs Amy Ernst and Gary
Smith - regarding whether they may have included any of the
participants’ data in more than one of their studies (Ernst 1990;
Ernst 1995a; Ernst 1995b; Ernst 1997; Smith 1996; Smith 1997a;
Smith 1997b; Smith 1998a). We did not need to request missing
data for the two new included studies (Jenkins 2014; Lee 2013).

Assessment of heterogeneity
We computed Chi2 values to test for heterogeneity. We noted
heterogeneity in the single comparison that could be statistically
combined, thus we used a random-effects model for meta-analysis.

Assessment of reporting biases

Measures of treatment effect

We followed instructions from Higgins 2011 (Version 5.1.0) regarding assessment of risk of reporting bias at the study level.

Dichotomous data

Data synthesis

We planned to analyse dichotomous data using Review Manager
(RevMan 5.3). Specifically, we would have computed the relative
risk. However, owing to lack of relevant data in the included studies, we did not analyse dichotomous data. The small number of
trials in each comparison group and the heterogeneity of outcome
measures precluded meta-analysis for most comparisons. Therefore, we performed a mostly descriptive analysis. For the comparison of topical prilocaine-phenylephrine (PP) and topical tetracaine-epinephrine-cocaine (TAC), reported outcomes (pain intensity measures) could be statistically combined, thus we pooled the
data. We performed statistical calculations by using Review Manager (RevMan 5.3).

The small number of trials in each comparison group and the
heterogeneity of outcome measures precluded meta-analysis for
most comparisons. Therefore, we performed a mostly descriptive
analysis.
In the prior version of this review, reported outcomes (pain intensity measures) for the comparison of topical PP and topical TAC
could be statistically combined, thus we pooled the data (Eidelman
2011).
We performed statistical calculations by using Review Manager
(RevMan 5.3).

Continuous data

We pooled participant self-reported VAS scores (which are continuous outcomes) using means and standard deviations (SDs) to
derive mean differences (MDs) as well as 95% confidence intervals
(CIs).

Subgroup analysis and investigation of heterogeneity
We intended to perform a subgroup analysis to determine whether
results were different between adult and paediatric participants.
We considered participants younger than 18 years old to be paediatric participants and those aged 18 years or older to be adults.
However, subgroup analysis by age was not possible because of the
small number of studies in each comparison group. Also, many
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trials included only paediatric or only adult participants. Moreover, studies that included both adult and paediatric participants
did not separately report outcomes for the different age groups.

Sensitivity analysis
We performed sensitivity analyses for inclusion or exclusion during
data collection by producing a table that reflected prespecified
inclusion and exclusion criteria.

’Summary of findings’ table and GRADE
In adherence with Higgins 2011 (Version 5.1.0), we populated a
’Summary of findings’ table for the primary outcome - pain control
during laceration repair. We used the GRADE system to assess
the overall quality of evidence (GRADEpro GDT 2015). Owing
to limitations in the number and design of retrieved studies, our
analysis was mostly descriptive and limited (Summary of findings
for the main comparison). However, we were successful in pooling
data for a comparison of topical PP and topical TAC (Summary
of findings 2) and for the primary outcome - pain control during
laceration repair.
The GRADE system categorizes level of quality as follows.
1. High = randomized trials; or double-upgraded
observational studies.
2. Moderate = downgraded randomized trials; or upgraded
observational studies.
3. Low = double-downgraded randomized trials; or
observational studies.
4. Very low = triple-downgraded randomized trials; or
downgraded observational studies; or case series/case reports.
We decreased the grade by one point for each of the following.

1. Limitations in the design and implementation of available
studies suggesting high likelihood of bias.
2. Indirectness of evidence (indirect population, intervention,
control, outcomes).
3. Unexplained heterogeneity or inconsistency of results
(including problems with subgroup analyses).
4. Imprecision of results (wide confidence intervals).
5. High probability of publication bias.
We increased the grade by one point for each of the following.
1. Large magnitude of effect.
2. All plausible confounding reducing a demonstrated effect
or suggesting a spurious effect when results show no effect.
3. Dose-response gradient.

RESULTS

Description of studies
Results of the search

Flow of studies

For this update, we identified two studies that met criteria for
inclusion (Jenkins 2014; Lee 2013). A total of 25 RCTs met the
inclusion criteria for this updated review. None of the 25 included
trials were industry sponsored. We have provided detailed descriptions of each trial in the Characteristics of included studies table.
We have presented detailed search results in Figure 1.
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Figure 1. Flow diagram.
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Details
In the previous version (Eidelman 2011), two review authors’ independent review of abstracts and titles identified by electronic
database searches (total 2820 articles before 2010) yielded 39 potentially relevant studies. We obtained each of these 39 trials in
full and examined them for possible inclusion in the review. Sixteen of the 39 retrieved trials did not meet the inclusion criteria.
Furthermore, we identified eight additional potentially relevant
papers through review of obtained study references (Bass 1990;
Bonadio 1988a; Bonadio 1988b; Chipont 2001; Liebelt 1997;
Peirluisi 1989; Yamamoto 1997) or by manual searches of journals
(Bonadio 1992). However, none of the eight papers met the inclusion criteria for this review. We have provided a detailed description of each of these 24 studies in the Characteristics of excluded
studies table.
From studies that presented results in bar graph format (Anderson
1990; Ernst 1990; Smith 1996; Smith 1997a; Smith 1997b; Smith
1998a), two review authors (AE, IE) independently extracted numerical data by measuring graphs with a ruler. We then calculated
the average of their two measurements. For one RCT, we calculated
the standard deviation (SD) for the mean pain score of each experimental group by multiplying the standard error of the mean (SEM)
by the square root of the sample size (Smith 1997b). For three
studies, we calculated mean pain scores and SDs from individual
participant data (Anderson 1990; Ernst 1990; Gaufberg 2007).
White and associates reported their results in separate groups according to characteristics of the laceration (length and location)
(White 1986). We pooled pain scores for each anaesthetic group
and reported the results collectively. Furthermore, to facilitate statistical comparisons, we converted VAS pain scores reported on a
10-cm scale to a 100-mm scale by multiplying scores by 10 (Adler
1998; Kuhn 1996; Zempsky 1997).
In the present update, independent review by two review authors
of abstracts and titles identified by electronic database searches (total 2633 articles published in 2010 to 2016) yielded 13 potentially
relevant studies. We obtained each of the 13 new trials in full and
examined them for possible inclusion in the review, in addition
to the 39 previously included studies. Eleven of the 13 retrieved
trials did not meet the inclusion criteria. We were unable to locate any unpublished studies that qualified for the present review,
despite direct communication with pertinent manufacturers and
investigators.

Most trials that compared infiltrated and topical anaesthetics were
at high risk of blinding, allocation concealment and/or sample
size bias, which is likely to affect interpretation of results. Several
cocaine-free topical anaesthetics were found to provide effective
analgesic efficacy. However, data regarding the efficacy of each
topical agent are based mostly on single comparisons in trials with
unclear or high risk of bias. Mild, self-limited erythematous skin
induration occurred in one case out of a total of 1042 participants
who underwent application of topical TAC. Researchers reported
no serious complications for any of the participants treated with
cocaine-based or cocaine-free topical anaesthetics.
Participants

Trials included a total of 3278 adult and paediatric participants. Four trials included only adult participants (Ernst 1995b;
Gaufberg 2007; Jenkins 2014; White 1986). One trial enrolled
only paediatric participants who were 10 years of age or younger
(Schaffer 1985). Another trial was limited to children, but investigators did not specify the upper age limit (Bonadio 1990). The
remaining 19 studies enrolled both adult and paediatric participants according to the definition provided above. Inclusion criteria applied in 10 of the retrieved trials potentially allowed children younger than three years old to be enrolled (Anderson 1990;
Blackburn 1995; Hegenbarth 1990; Pryor 1980; Schaffer 1985;
Schilling 1995; Smith 1996; Smith 1997a; Smith 1997b; Smith
1998a). The trials by Ernst and Smith included no duplicate participant data (Ernst 1990; Ernst 1995a; Ernst 1995b; Ernst 1997;
Smith 1996; Smith 1997a; Smith 1997b; Smith 1998a).
Interventions

Wound closure
Investigators in 23 studies performed wound closure solely with
sutures. In one study, researchers repaired lacerations using both
sutures and staples (Krief 2002). In another trial, clinicians repaired lacerations by using skin staples in a minority (7%) of
participants (Hegenbarth 1990). Researchers reported no alternative techniques of wound repair. Lacerations were located in four
anatomical regions: face, scalp, extremities and, less commonly, the
trunk. All lacerations were superficial, and dermal injuries ranged
from less than 1.0 cm to 10.0 cm in length.

Included studies
We included 25 RCTs involving 3278 participants. The small
number of trials in each comparison group and the heterogeneity
of outcome measures precluded quantitative analysis of data for all
but one outcome: pain intensity assessed on a visual analogue scale.

Topical anaesthetics
The 25 included RCTs studied different topical anaesthetics (listed
in Appendix 6). Four studies included multiple arms that compared more than two different anaesthetic agents (Smith 1996;
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Smith 1997a; Smith 1997b; Smith 1998a). Smith 1996 included
six different groups, including five different topical anaesthetics
and an infiltrated local anaesthetic arm. Smith 1997a evaluated
two topical anaesthetics and infiltrated local anaesthetic. Smith
1997b compared four different topical anaesthetics, and Smith
1998a studied three different topical agents.
Seventeen of the 25 studies compared different forms of topical
anaesthetics, and only a minority of trials contained arms with infiltrated local anaesthetic groups. Therefore, the main comparison
involved different topical preparations.
We performed no subgroup analysis (or meta-regression) owing
to the small number of trials in each comparison group.

scribe anaesthetic effectiveness (Pryor 1980; Resch 1998; Schaffer
1985; Schilling 1995; Smith 1996; Smith 1997b; Vinci 1996).
Two studies employed an observer-reported compliance rating
(Anderson 1990; Smith 1996), and two RCTs used observer-rated
acceptability of wound repair (Kendall 1996; Pryor 1980). Two
studies reported the total number of topical anaesthetic doses
(Gaufberg 2007; Vinci 1996). Each of the following secondary
outcome measures was used by a single trial: the Childrens Hospital of Eastern Ontario Pain Scale (CHEOPS) (Kuhn 1996), observer numerical rating of anaesthetic effectiveness (Ernst 1990),
the Restrained Infants, Children Distress Rating Scale (RICDRS)
(Smith 1996) and the amount of local anaesthetic used (Gaufberg
2007).

Outcomes
Our primary outcome measure was analgesic efficacy, as reflected in participants’ self-reports of pain intensity during repair
of the wound. Fifteen of the included trials determined anaesthetic efficacy through the participants’ self-reports of pain intensity (Blackburn 1995; Ernst 1995a; Ernst 1995b; Ernst 1997;
Gaufberg 2007; Jenkins 2014; Kendall 1996; Krief 2002; Kuhn
1996; Lee 2013; Smith 1996; Smith 1997b; Smith 1998a; White
1986; Zempsky 1997). Unless otherwise specified, investigators
assessed discomfort during suturing or stapling and used multiple
tools for participant self-report of pain intensity. Twelve studies
used VAS pain scale scores (Ernst 1995b; Ernst 1997; Gaufberg
2007; Jenkins 2014; Kendall 1996; Krief 2002; Kuhn 1996; Lee
2013; Smith 1996; Smith 1997b; Smith 1998a; Zempsky 1997).
Three RCTs used a Faces pain scale (Blackburn 1995; Kendall
1996; Kuhn 1996), and two trials used verbal numerical pain ratings (0 to 10) (Ernst 1995a; White 1986).
We extracted secondary outcome measures from the RCTs. Nine
trials provided observer-reported VAS pain intensity scores (Ernst
1995b; Ernst 1997; Kendall 1996; Krief 2002; Kuhn 1996; Smith
1996; Smith 1997a; Smith 1998a; Zempsky 1997). Three studies
used observer-rated Likert scores for pain intensity (Smith 1996;
Smith 1997a; Smith 1997b). Two RCTs used observer-reported
Faces pain scales (Blackburn 1995; Kuhn 1996), and one used
an observer-rated multi-dimensional pain intensity scale (Ernst
1995a). Four trials calculated the percentage or absolute number
of sutures eliciting pain (Bonadio 1990; Ernst 1995a; Ernst 1995b;
Ernst 1997), and 11 studies reported the requirement for supplemental lidocaine infiltration (Anderson 1990; Blackburn 1995;
Ernst 1995a; Ernst 1997; Hegenbarth 1990; Jenkins 2014; Krief
2002; Schaffer 1985; Vinci 1996; White 1986; Zempsky 1997).
Eight RCTs assessed the effectiveness of anaesthesia by probing
the laceration with a needle (Anderson 1990; Ernst 1990; Ernst
1997; Hegenbarth 1990; Jenkins 2014; Kuhn 1996; Resch 1998;
Schilling 1995), and seven included a verbal categorical scale to de-

Adverse effects
Thirteen trials explicitly assessed and reported the nature and
incidence of topical local anaesthetic-related acute adverse effects (Blackburn 1995; Bonadio 1990; Ernst 1990; Ernst 1995a;
Hegenbarth 1990; Jenkins 2014; Kendall 1996; Kuhn 1996; Lee
2013; Resch 1998; Schaffer 1985; Schilling 1995; Vinci 1996).

Excluded studies
We excluded 36 studies for one of the following reasons: not an
RCT, outcomes of interest not measured, irrelevant study (i.e.
study involved use of local anaesthetics for other than skin laceration purposes), participants sedated, mucosal laceration or wound
closed with adhesive. Further information can be found in the
Characteristics of excluded studies section and in Figure 1.

Studies awaiting classification
We identified no studies awaiting classification.

Ongoing studies
We identified one ongoing study but excluded it, as it did not
meet our inclusion criteria (Ridderikhof 2015); this study was an
observational case series - not an RCT.

Risk of bias in included studies
For this updated review, we analysed risk of bias in the 25 included
trials by assessing randomization (sequence generation), blinding,
allocation concealment, incomplete outcome data, selective reporting and sample size. Further information regarding risk of
bias can be found in the ’Risk of bias’ graph (Figure 2), summary
(Figure 3) and tables (Characteristics of included studies).
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.

Allocation
Allocation was adequately concealed in six of the 25 studies (24%)
(Blackburn 1995; Ernst 1995b; Jenkins 2014; Kuhn 1996; Resch
1998; Schilling 1995) and was unclear in seven other studies (28%)
(Ernst 1990; Krief 2002; Smith 1996; Smith 1997a; Smith 1997b;
Smith 1998a; Lee 2013).
Random sequence generation was adequate in seven of the 25
trials (28%) (Ernst 1995a; Ernst 1995b; Ernst 1997; Jenkins 2014;
Resch 1998; Vinci 1996; Zempsky 1997), and information was
insufficient to allow a judgement in 10 studies (40%) (Ernst 1990;
Gaufberg 2007; Krief 2002; Kuhn 1996; Lee 2013; Schilling
1995; Smith 1996; Smith 1997a; Smith 1997b; Smith 1998a).

Blinding
Thirteen of 25 studies (52%) adequately blinded participants and
personnel to the identity of the anaesthetic (Blackburn 1995;
Bonadio 1990; Ernst 1990; Ernst 1995a; Ernst 1995b; Kuhn
1996; Resch 1998; Schaffer 1985; Schilling 1995; Smith 1996;
Smith 1997a; White 1986; Zempsky 1997). Information was insufficient in four papers (17%) to confirm adequate blinding (Krief
2002; Smith 1997b; Smith 1998a; Vinci 1996). However, 13 of 17
studies (76%) that compared different forms of topical anaesthetics were appropriately blinded. Nine of the 10 trials that compared
topical anaesthetic versus infiltrated anaesthetic were not blinded
(Anderson 1990; Ernst 1997; Gaufberg 2007; Hegenbarth 1990;

Jenkins 2014; Kendall 1996; Lee 2013; Pryor 1980; Smith 1996).
One trial (Smith 1997a) was adequately blinded because after
the topical or local anaesthetic was administered, investigators
videotaped suturing procedures. An observer who was completely
blinded to which form of anaesthetic the participant had received
later reviewed these videotapes.

Incomplete outcome data
Twelve trials (48%) appropriately addressed incomplete outcome
data (Anderson 1990; Ernst 1990; Ernst 1995a; Gaufberg 2007;
Jenkins 2014; Kendall 1996; Kuhn 1996; Lee 2013; Pryor 1980;
Schilling 1995; Vinci 1996; Zempsky 1997). Researchers did so
because they noted a balance in the number of excluded participants between different groups (reasons for exclusion are unlikely
to be related to pain scores during the trial), or because they reported no drop-outs or exclusions. Attrition bias was unclear in
12 studies (48%) (Blackburn 1995; Bonadio 1990; Ernst 1997;
Hegenbarth 1990; Krief 2002; Resch 1998; Schaffer 1985; Smith
1996; Smith 1997a; Smith 1997b; Smith 1998a; White 1986).

Selective reporting
We concluded that 19 (76%) articles described all outcomes in the
Methods section and adequately reported study results (Blackburn
1995; Bonadio 1990; Ernst 1995a; Ernst 1995b; Ernst 1997;
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Gaufberg 2007; Hegenbarth 1990; Jenkins 2014; Kendall 1996;
Krief 2002; Lee 2013; Schaffer 1985; Smith 1996; Smith 1997a;
Smith 1997b; Smith 1998a; Vinci 1996; White 1986; Zempsky
1997). We found unclear selective reporting bias in five articles
(20%) (Anderson 1990; Ernst 1990; Kuhn 1996; Resch 1998;
Schilling 1995) (e.g. subgroup analysis based on laceration location, sex or age not prespecified).

Six studies compared a topical cocaine-based agent versus infiltrated local anaesthetic (see Table 1 for detailed study information). Five studies compared topical TAC versus infiltrated local
anaesthetic. We could not mathematically combine outcomes because of the diversity of measures used to assess anaesthetic efficacy (Anderson 1990; Hegenbarth 1990; Pryor 1980; Smith 1996;
Smith 1997a); these five studies enrolled a total of 1194 participants.

Other potential sources of bias
Primary outcome: participant report of pain intensity during
wound repair
Sample size bias

Thirteen (52%) studies had unclear sample size risk, defined as 50
to 200 participants per treatment arm (Ernst 1990; Ernst 1995b;
Gaufberg 2007; Jenkins 2014; Kendall 1996; Kuhn 1996; Pryor
1980; Resch 1998; Schaffer 1985; Schilling 1995; Smith 1996;
Smith 1997b; Smith 1998a); most of these included 60 to 70
participants per treatment arm. We found only one study with
low risk, defined as more than 200 participants per treatment arm
(Hegenbarth 1990); one arm included 262 participants, and the
other included 205.

Effects of interventions
See: Summary of findings for the main comparison Primary
outcome: topical local anaesthetics compared with infiltrated
local anaesthetics or other topical agents for repair of dermal
lacerations; Summary of findings 2 Primary outcome subanalysis:
pain intensity measures of topical prilocaine-phenylephrine (PP)
and topical tetracaine-epinephrine-cocaine (TAC)
We first present the evidence regarding cocaine-containing topical anaesthetics. We included comparisons between cocaine-based
topical anaesthetics and each of the following: (1) infiltrated local
anaesthetics; and (2) different formulations of cocaine-based topical agents. Next, we summarize the evidence evaluating cocainefree topical anaesthetics. We compared cocaine-free topical agents
with each of the following: (1) infiltrated local anaesthetics; (2)
formulations of cocaine-containing topical agents; and (3) different formulations of cocaine-free topical anaesthetics; both of the
newly included studies (Jenkins 2014; Lee 2013) belong to category “2a”.
We also report the data on acute anaesthetic-related adverse effects.
We have provided a detailed and inclusive description of each of
the 25 trials in the Characteristics of included studies table.
Intervention 1. Evaluation of cocaine-containing
topical anaesthetics

1a. Cocaine-containing topical anaesthetics versus local
anaesthetic infiltration (six studies)

Anaesthetic efficacy measures for topical TAC were inconsistent
in efficacy reporting. One study found that topical adrenalinecocaine (AC) provided analgesia equivalent to that of local anaesthetic infiltration (Kendall 1996).
Secondary outcomes: indirect predictors of pain intensity
during wound repair
1. Adequate initial anaesthesia and/or requirement for
supplemental lidocaine: Anderson 1990 and Hegenbarth 1990
found minimal differences between comparison groups.
However, Smith 1997a found that fewer participants in the TAC
group than in the Mepivanor group needed supplemental
lidocaine rescue owing to inadequate anaesthesia as assessed by
suture technicians (2, or 8.3%, vs 9, or 37.5%, respectively; P =
0.04).
2. Participant compliance during suturing: Anderson 1990
found that participant compliance during suturing for TAC was
significantly better than for lidocaine or placebo (P < 0.002).
3. Participant preference: Hegenbarth 1990 reported that
92% of parents of participants who received TAC for facial or
scalp laceration repair preferred it for the future compared with
57% of parents whose children received lidocaine (P < 0.0001).
The difference in parent preference was not statistically
significant for other body areas. Pryor 1980 reported that parents
of children between one and five years of age preferred topically
applied TAC over infiltrated lidocaine (P < 0.005), and that
participants five to 17 years old self-reported an even more
significant preference for TAC (P < 0.0001).
4. Duration of procedure: Pryor 1980 found that the duration
of the suturing procedure was significantly shorter for topical
TAC than for infiltrated lidocaine in the one- to five-year-old age
group (P < 0.005). For participants 11 to 17 years old, results
similarly suggested that the procedure for the TAC group had a
shorter duration, but this finding was not statistically significant.
Data showed no duration difference between other age groups
studied. Smith 1996 reported no difference in the duration of
suturing between TAC and lidocaine infiltration in all age groups
studied (two to 17 years old; P = 0.15).
5. Observer VAS ratings: Smith 1996 found that VAS ratings
by observers (suture technicians and research assistants) and
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participants showed that, compared with lidocaine infiltration,
Bupivanor had a small but statistically significantly superior
performance for face and scalp lacerations. In the same study,
Bupivanor outperformed TAC for repair of face and scalp
lacerations, but this finding did not reach statistical significance.
Smith 1997a showed statistically significantly higher VAS scores
(i.e. poorer pain control), as observed by research assistants or
technicians, with topical Mepivanor solution than with TAC or
lidocaine.
6. Failed anaesthesia: Kendall 1996 found a higher incidence
of failed anaesthetics in the lidocaine group than in the AC
group (24% vs 10%; P < 0.01).
7. Acute adverse effects and toxicity: Please see “Intervention
3. Anaesthetic-related acute adverse effects” subsection below.

Evidence quality
Kuhn 1996 had unclear risk of bias for sequence generation but
low risk of bias for the other three key domains. Bonadio 1990 did
not use a formal pain scoring scale to assess the efficacy of AC and
had high risk of bias for both sequence generation and allocation
concealment.
Although the trials mentioned were RCTs, we downgraded the
overall GRADE score for each measured outcome to low owing to
limitations in design and implementation, imprecision of results
and high probability of publication bias (selective reporting of
data) (see Characteristics of included studies).

Intervention 2. Evaluation of cocaine-free topical
anaesthetics

Evidence quality for primary and secondary outcomes
The following trials had high risk of bias in multiple domains
(Anderson 1990; Hegenbarth 1990; Pryor 1980) or unclear risk
of bias in three domains (Smith 1996; Smith 1997a). One study
found that topical AC provided equivalent analgesia to local anaesthetic infiltration (Kendall 1996). However, this study was not
blinded and risk of bias was high for both sequence generation and
allocation concealment. In conclusion, although the trials mentioned were RCTs, we downgraded the overall GRADE score for
each measured outcome to low owing to limitations in design and
implementation, imprecision of results and high probability of
publication bias (selective reporting of data) (see Characteristics
of included studies).

1b. Comparisons between different cocaine-containing
topical anaesthetics (four studies)

Four studies with 530 participants in total compared topical TAC
versus another cocaine-based topical anaesthetic (Table 2).

Primary outcome: participant report of pain intensity during
wound repair
Anaesthetic efficacy did not differ between TAC and either topical
bupivacaine-adrenaline-cocaine (Marcain (Astra)-adrenaline-cocaine (MAC) (Kuhn 1996) or adrenaline-cocaine (AC) (Bonadio
1990)). Neither cocaine (C) (Ernst 1990) nor tetracaine-cocaine
(TC) (Vinci 1996) was found to be an effective topical anaesthetic.

Secondary outcome: indirect predictors of pain intensity
during wound repair
Acute adverse effects and toxicity: Please see “Intervention 3.
Anaesthetic-related acute adverse effects” subsection below.

2a. Cocaine-free topical anaesthetics versus infiltrated local
anaesthetic (six studies)

Six RCTs with 627 total participants compared five different cocaine-free topical anaesthetics versus infiltrated local anaesthetic
(Table 3). We could not mathematically combine the two studies of topical mepivacaine-noradrenaline (MN) because of heterogeneity in outcome measures, and Smith 1996 did not report SDs
for pain scores.

Primary outcome: participant report of pain intensity during
wound repair
Smith 1996 found no significant differences in VAS pain scores between infiltrated lidocaine and four different noradrenaline-containing topical anaesthetics, including bupivacaine-noradrenaline
(BN), etidocaine-noradrenaline (EN), mepivacaine-noradrenaline
(MN) and prilocaine-noradrenaline (PN). Smith 1997a also compared topical MN with infiltrated lidocaine and found that the
latter provided better analgesia. Researchers found no significant
differences between infiltrated local anaesthetic and either topical
lidocaine-adrenaline-tetracaine (LAT) (Ernst 1997) or topical lidocaine-epinephrine (TLE) (Gaufberg 2007).
Jenkins 2014 compared topical anaesthetic putty (4.94% lidocaine
HCl, equivalent to 4% lidocaine base) to a maximum of 10 grams
versus infiltrated lidocaine 1% for pain during suturing in 54 and
56 participants, respectively. Mean pain score during suturing was
0.78 ± 1.12 (SD) on a 0 to 10 VAS after lidocaine infiltration
versus 1.49 ± 1.76 after topical anaesthetic putty. Both one-sided
95% confidence interval (CI) limits plus (owing to their non-normal distribution) non-parametric comparisons of median scores
showed non-inferiority of topical anaesthetic putty compared with
infiltrated lidocaine.
Lee 2013 compared topical anaesthetic gel comprising LAT (4%
lidocaine, 1:2000 adrenaline, 1% tetracaine) versus lidocaine 1%
infiltration in 23 and 17 participants, respectively, for pain during
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suturing. Investigators reported the dosage for neither group. The
LAT gel group reported a mean (± standard error (SE)) pain intensity of 2.5 (0.52) versus 2.6 (0.58) for lidocaine infiltration. Pain
during LAT application was 1.5 (0.40) versus 2.6 (0.58) during
lidocaine infiltration (P ≤ 0.01). Researchers concluded that LAT
gel for repair of minor lacerations was as efficacious as infiltrated
lidocaine in terms of participant comfort.

Secondary outcome: indirect predictors of pain intensity
during wound repair
Jenkins 2014 reported that:
1. the number of participants requiring rescue anaesthesia was
three of 56 (5.3%) in the lidocaine infiltration group and four of
54 (7.4%) in the topical anaesthetic putty group; and
2. the “wound evaluation score” obtained seven to 10 days
after treatment showed that 12 of 54 (22.22%) in the topical
anaesthetic putty group had less than perfect scores versus five of
56 (8.9%) in the infiltration group.
Ernst 1997 found no difference in effectiveness of LAT compared
with injected lidocaine as reported by physicians (P = 0.83). The
number of sutures causing pain was not statistically significantly
different (P = 0.28).
Gaufberg 2007 found that 95% of participants given TLE rated
their experience as “excellent,” compared with 5% of participants
in the control group (P < 0.001). Anaesthesia lasted significantly
longer for LTE than for control (P < 0.001) and the amount of
lidocaine in the TLE application was comparable with that in the
control (P 0.90).
Smith 1996 found that observers rated Bupivanor as being as effective as TAC and 1% lidocaine infiltration. Smith 1997a showed
statistically significantly higher VAS scores (i.e. worse pain control)
assessed by observers for Mepivanor than for TAC or lidocaine.
For reported acute adverse effects and toxicity, see the “Intervention 3. Anaesthetic-related acute adverse effects” subsection below.

Evidence quality for primary and secondary outcomes
Both of the trials by Smith and associates had unclear risk of bias
in at least three key domains. Also, in Smith 1996, comparisons
of infiltrated lidocaine and topical anaesthetics were not blinded.
Moreover, Smith 1997a did not employ participant self-reported
pain scoring scales but instead relied on observer estimates of pain.
None of these trials were blinded: Ernst 1997; Gaufberg 2007;
Jenkins 2014; Lee 2013. Ernst 1997; Gaufberg 2007; and Lee
2013did not properly perform or describe allocation concealment.
Again, although the trials mentioned were RCTs, we downgraded
the overall GRADE score for each measured outcome to low owing
to limitations in design and implementation, imprecision of results
and a high probability of publication bias (selective reporting of
data) (see Characteristics of included studies).

2b. Cocaine-free topical anaesthetics versus cocainecontaining topical anaesthetics (11 studies)

Eleven trials with a total of 1314 participants compared 13 different cocaine-free topical anaesthetics versus topical TAC (Table
4).Each of these studies employed TAC as the cocaine-containing
topical preparation.

Primary outcome: participant report of pain intensity during
wound repair
Smith and associates published four papers relevant to this
comparison (Smith 1996; Smith 1997a; Smith 1997b; Smith
1998a). In comparisons confined to a single application, Smith
and associates found similar analgesic efficacy between topical
TAC and each of the following topical agents: bupivacaine-noradrenaline (BN), prilocaine-noradrenaline (PN), tetracaine-lidocaine-phenylephrine (TLP) and tetracaine-phenylephrine (TP)
(Smith 1996; Smith 1997b). Two papers compared topical prilocaine-phenylephrine (PP) versus topical TAC (Smith 1997b;
Smith 1998a). In Analysis 1.1, we pooled participant-reported
VAS (100 mm) pain scores and found no differences between topical PP and topical TAC (weighted mean difference (WMD) 5.56,
95% CI -2.20 to 13.32).
Two studies presented conflicting conclusions regarding the efficacy of topical MN (Smith 1996; Smith 1997a). We could not
statistically combine these trials because investigators used different pain intensity scales to determine anaesthetic efficacy, and
Smith 1996 did not report standard deviations for study outcomes. Three studies found similar efficacy between topical LAT
and TAC (Ernst 1995a; Ernst 1995b; Schilling 1995). One RCT
found no difference in pain scores among children anaesthetized
with EMLA cream (lidocaine 2.5% and prilocaine 2.5%) or topical TAC (Zempsky 1997). Blackburn 1995 found no difference
in the efficacy of topical lidocaine-adrenaline (LE) versus topical TAC. Topical TAC was superior to etidocaine-noradrenaline
(Smith 1996), topical bupivacaine-phenylephrine (Smith 1998a),
topical tetracaine-adrenaline (Schaffer 1985) and topical tetracaine (White 1986).

Secondary outcome: indirect predictors of pain intensity
during wound repair
Ernst 1995b reported that physicians found that LAT was more effective than TAC during suturing (P = 0.0093). Smith 1996 found
that observers rated Bupivanor as being as effective as TAC and
1% lidocaine infiltration. Smith 1997a showed statistically significantly higher observer-reported VAS scores (i.e. more intense
pain) for Mepivanor than for TAC or lidocaine. Smith 1997b reported statistically significant inferiority of Prilophen versus TAC
using Likert scale scores provided by suture technicians and research assistants, but not by parents. Schilling 1995 found a statistically significant difference between TAC and LET in duration
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of anaesthesia on the cheek or chin area (X2 ; P = 0.04). Smith
1998a reported no statistically significant differences between the
effectiveness of prilocaine-phenylephrine and TAC for any of the
observer groups. Schaffer 1985 found drowsiness or excitability
following use of TAC in 10.7% versus 7.8% in the tetracaine and
adrenaline groups, respectively - a statistically insignificant difference. For acute adverse effects and toxicity, please see the effects
subsection “Intervention 3. Anaesthetic-related acute adverse effects” below.
Evidence quality for primary and secondary outcomes
Each of the four trials by Smith and associates had unclear risk of
bias for three or more key domains. Zempsky 1997 did not conceal allocation appropriately. Blackburn 1995 seems not to have
employed random sequence generation: “The TAC and TLE solutions were arbitrarily assigned to single-dose (10 mL), sequentially numbered vials by the pharmacist”. It was unclear whether
Schilling 1995 used appropriate sequence generation but risk of
bias was low for the other domains. The two trials by Ernst and
associates (Ernst 1995a; Ernst 1995b) had high risk of bias for
one key domain. We could not merge results because we found
heterogeneity in outcome measures.
Again, although the trials mentioned were RCTs, we downgraded
the overall GRADE score for each measured outcome to low owing
to limitations in design and implementation, imprecision of results
and high probability of publication bias (selective reporting of
data) (see Characteristics of included studies).
2c. Comparisons between different cocaine-free topical
anaesthetics (five studies)

Five RCTs with 895 total participants evaluated different cocainefree topical anaesthetics (Table 5).
Primary outcome: participant report of pain intensity during
wound repair
Smith 1996 found no significant differences in anaesthetic efficacy between four different noradrenaline-containing topical
anaesthetics, including bupivacaine-noradrenaline (BN), etidocaine-noradrenaline (EN), mepivacaine-noradrenaline (MN) and
prilocaine-noradrenaline (PN). Another multi-arm RCT (Smith
1997b) demonstrated no significant differences between three
different topical formulations that contained the vasoconstrictor
phenylephrine, including prilocaine-phenylephrine (PP), tetracaine-phenylephrine (TP) and tetracaine-lidocaine-phenylephrine
(TLP). A third trial by the same primary author concluded that
topical PP and bupivacaine-phenylephrine (BP) had similar efficacy (Smith 1998a). Krief 2002 found no significant differences between pain scores among participants treated with topical
EMLA or LAT. Resch 1998 concluded that the solution and gel
formulations of LAT provided comparable analgesic efficacy.

Secondary outcome: indirect predictors of pain intensity
during wound repair
Krief 2002 presented higher physician-reported VAS scores (i.e.
poorer pain control) when using EMLA compared with LAT. For
acute adverse effects and toxicity, please see the effects subsection
”Intervention 3. Anaesthetic-related acute adverse effects“ below.

Evidence quality for primary and secondary outcomes
Each of the papers by Smith and associates, as well as theKrief
2002 study, had unclear risk of bias in at least three domains.
Resch 1998 showed unclear management of incomplete data but
otherwise was at low risk of bias.
Again, although the trials mentioned were RCTs, we downgraded
the overall GRADE score for each measured outcome to low owing
to limitations in design and implementation, imprecision of results
and high probability of publication bias (selective reporting of
data) (see Characteristics of included studies).

Intervention 3. Anaesthetic-related acute adverse
effects
Approximately half of the included trials (12/25 enrolling 1713
participants) reported data regarding the incidence of potential
anaesthetic-related acute adverse effects. We have displayed details
in Summary of findings for the main comparison. Studies reported
only one episode of a local anaesthetic-related complication (acute
toxicity or subacute adverse effects). In Vinci 1996, a single paediatric participant developed a large indurated, erythematous reaction one day after application of topical TAC. The skin reaction completely resolved with antihistamine treatment and warm
compresses, and investigators described no other incidents of local
anaesthetic-induced reactions or toxicity. Schaffer 1985 reported
that after discharge home, 10.7% of children treated with TAC
and 7.8% who received topical AC became drowsy or excitable.
However, none of these symptoms occurred in the emergency department, and no evidence suggested that symptoms were causally
related to the topical anaesthetic. Two trials that included an infiltrated local anaesthetic group reported data on acute side effects
(Hegenbarth 1990; Kendall 1996). None of the combined 256
participants administered local anaesthesia via infiltration in these
two studies reported any adverse effects.
Ten different RCTs that studied cocaine-based topical anaesthetics explicitly reported information about acute adverse effects (Blackburn 1995; Bonadio 1990; Ernst 1990; Ernst 1995a;
Hegenbarth 1990; Kendall 1996; Kuhn 1996; Schaffer 1985;
Schilling 1995; Vinci 1996). Pooled data on 1042 participants
from these 10 trials showed only a single acute adverse reaction
(incidence 0.096%). This complication (local induration in a paediatric participant) was not serious and is described above. A total
of five RCTs that used cocaine-free topical agents reported data
on anaesthetic-related toxicity or side effects (Blackburn 1995;
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Ernst 1995a; Resch 1998; Schaffer 1985; Schilling 1995). None
of the 358 participants in these five RCTs experienced any acute
adverse reactions. Lee 2013 reported wound complications as a
secondary outcome. Participants assigned to receive LAT gel developed infection (five participants), dehiscence (one participant)
and missing sutures (one participant). Corresponding outcomes
in the lidocaine infiltration group included infection in two of 14
participants, dehiscence in none and lost sutures in none. Again,
studies found that LAT and infiltrated lidocaine have comparable
side effect profiles. Jenkins 2014 reported wound infection (four
cases in the infiltration group vs two in the topical anaesthetic
putty group); wound dehiscence (two cases in the topical anaesthetic putty group); and adverse effects (one inflamed wound in
the topical anaesthetic putty group and one wound requiring resuturing in both groups).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]

Prim ary outcom e subanalysis: pain intensity m easures of topical prilocaine-phenylephrine (PP) and topical tetracaine-epinephrine-cocaine (TAC)
Patient or population: treatm ent repair of derm al laceration
Setting: any m edical setting
Intervention: topical prilocaine-phenylephrine (PP)
Comparison: topical tetracaine-epinephrine-cocaine (TAC)
Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

Number of participants Quality of the evidence Comments
(studies)
(GRADE)

Risk with topical tetra- Risk
caine- epinephrinewith topical prilocainecocaine (TAC)
phenylephrine (PP)
Participant
self -re- M ean participant self - M ean participant self - ported VAS (0-100 m m ) reported VAS (0-100 reported VAS (0-100
pain scores
m m ) pain score was 0 m m ) pain scores in the
intervention group was
5.59

240
(2 studies)

Low a

5.59 (95% CI f or ef f ect
estim ate, 2.16 to 13.35)

* Risk in the intervention group (and its 95% conf idence interval) is based on assum ed risk in the com parison group and the relative effect of the intervention (and its 95% CI).
CI: conf idence interval; OR: odds ratio; RR: risk ratio.
GRADE Working Group grades of evidence.
High quality: We are very conf ident that the true ef f ect lies close to the estim ate of ef f ect.
M oderate quality: We are m oderately conf ident in the ef f ect estim ate: The true ef f ect is likely to be close to the estim ate of ef f ect but m ay be substantially dif f erent.
Low quality: Our conf idence in the ef f ect estim ate is lim ited: The true ef f ect m ay be substantially dif f erent f rom the estim ate of ef f ect.
Very low quality: We have very little conf idence in the ef f ect estim ate: The true ef f ect is likely to be substantially dif f erent f rom the estim ate of ef f ect
a Each

of the trials had unclear risk of bias in one or m ore dom ains. However, no trials included any dom ains that were clearly
at high risk.
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DISCUSSION
The topic of the present review is limited to repair of dermal lacerations. Therefore, the results may not be generalizable to repair
of wounds located on mucosal surfaces. Also, the dermis provides
a barrier to penetration of topical anaesthetic, and so our findings
may not be applicable to instrumentation of intact skin.

Summary of main results
The present review consists of a descriptive analysis. Two predominant limitations precluded meta-analysis. First, most of the comparisons between specific anaesthetic agents were accomplished in
single trials. Only in a few instances were agents compared across
multiple studies. Moreover, trials employed numerous measures
of anaesthetic efficacy. In fact, only 15 of the 25 included studies
used a validated pain scale. The primary outcome measure was
analgesic efficacy, reflected in the participant’s self-report of pain
intensity during repair of the wound. We extracted surrogate pain
scores provided by observers; however, participants’ and practitioners’ assessments of procedure-related pain reveal non-concordance (Choiniere 1990; Singer 1999; Stephenson 1994). Therefore, during analysis, we considered surrogate pain scores only
when participant-reported pain scales were not available.

Overall completeness and applicability of
evidence
Our systematic review addressed four principal questions regarding topically applied local anaesthetics for dermal laceration repair.
First, we assessed whether benefits of non-invasive, topical anaesthetic application occur at the expense of decreased analgesic efficacy. We obtained data from a single study that had unclear risk
of blinding bias(Smith 1997a); the remainder of the trials were at
high risk of blinding bias (Anderson 1990; Ernst 1997; Gaufberg
2007; Hegenbarth 1990; Jenkins 2014; Kendall 1996; Lee 2013,
Pryor 1980; Smith 1996). Smith 1997a did not use participant
self-reported pain scores to determine anaesthetic efficacy but instead used observer-estimated pain scores. Therefore, we found
a paucity of high-quality studies with low risk of bias on which
we could base definitive conclusions regarding efficacy of topical
anaesthetics versus infiltrated local anaesthesia.
Our second objective was to compare the efficacy of various single-component or multi-component topical anaesthetic agents for
repair of dermal lacerations. We obtained data from studies that
had unclear risk of bias (Ernst 1990; Kuhn 1996; Schilling 1995;
Smith 1996; Smith 1997a; Smith 1997b; Smith 1998a) or high
risk of bias (Blackburn 1995; Bonadio 1990; Ernst 1995a; Ernst
1995b; Jenkins 2014; Lee 2013; Schaffer 1985; Vinci 1996; White
2004; Zempsky 1997). We have summarized the findings of individual trials in Table 2, Table 3, Table 4 and Table 5. However,

the evidence reflects bias that may cause some doubt about the
findings, or may even significantly weaken the results.
The third objective was to determine the clinical necessity for
topical application of the ester anaesthetic, cocaine. We included
in the review 13 randomised controlled trials (RCTs), which assessed the effectiveness of cocaine-free topical anaesthetics. None
of these studies were at low risk of bias. We mathematically combined data from two studies and found that topical prilocainephenylephrine (PP) provided effective analgesia (Smith 1997b;
Smith 1998a). However, both of these studies had unclear risk
of bias for each key domain, leading to some uncertainty about
the results. A single RCT assessed each of the additional formulations of topical cocaine-free anaesthetics. Results from studies with unclear risk of bias show that the following agents may
provide effective topical analgesia: lidocaine-adrenaline-tetracaine
(LAT) (Schilling 1995), bupivacaine-noradrenaline (BN) (Smith
1996), prilocaine-noradrenaline (PN) (Smith 1996), tetracaine-lidocaine-phenylephrine (TLP) (Smith 1997b), tetracaine-phenylephrine (TP) (Smith 1997b) and lidocaine-prilocaine (EMLA)
(Krief 2002). Topical LAT, which exploits the rapid onset of lidocaine and the long duration of tetracaine (Altman 1985), has
been the most widely studied cocaine-free formulation. However,
before definitive conclusions can be reached, additional investigation is warranted through trials that are well designed and are
conducted to assess anaesthetic efficacy by using validated patient
self-reported pain scoring scales.
Finally, we evaluated the safety of both cocaine-containing and
cocaine-free topical anaesthetics. Many of the included trials (14
of 25) reported data regarding the incidence of anaesthetic-related
acute adverse effects. Only one study reported a topical local anaesthetic-related side effect (Vinci 1996). The reaction consisted of a
large indurated, erythematous reaction that occurred after topical
application of tetracaine-epinephrine-cocaine (TAC). No trials reported serious complications, such as seizures or anaphylactic reactions. Although reported data are insufficient to reveal the exact
incidence of complications, if topical anaesthetics are applied as
directed and appropriately dosed, serious adverse effects are probably infrequent. Combined observations from 10 trials that administered cocaine-based agents and explicitly reported data on
side effects revealed one adverse reaction among 1042 total participants (incidence 0.096%). Ten studies that administered cocainefree anaesthetic agents reported data on toxicity, and none of the
participants in these groups experienced acute adverse reactions.

Quality of the evidence
The present review consists of a descriptive analysis. Two predominant limitations precluded meta-analysis. First, most of the
comparisons between each of the specific anaesthetic agents were
accomplished in one trial. Only in a few instances were similar
agents compared in multiple studies. Moreover, trials employed
diverse outcome measures to determine anaesthetic efficacy. In
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fact, only 15 of the 25 included studies used a validated pain scale.
The primary outcome measure was analgesic efficacy, reflected
in participants’ self-report of pain intensity during repair of the
wound. We extracted surrogate pain scores provided by observers
and found that participants’ and practitioners’ assessments of procedure-related pain showed non-concordance (Choiniere 1990;
Singer 1999; Stephenson 1994). Therefore, our analysis employed
surrogate pain scores only when participant-reported pain scores
were not available.
In conclusion, although the trials mentioned were RCTs, we downgraded the overall GRADE score for each measured outcome to
low owing to limitations in design and implementation, imprecision of results and high probability of publication bias (selective
reporting of data) (see Characteristics of included studies).

Potential biases in the review process
Cochrane support staff conducted the search for this review to ensure comprehensiveness and inclusion of all possible studies. We
have assessed all types of bias required by the 2011 version of the
Higgins Cochrane Handbook for Systematic Reviews of Interventions
(version 5.1.0). Two independent review authors judged inclusion
or exclusion of articles to strengthen the decision-making process.
We included all reported participants without exclusion due to
gender, age or comorbid health issues. We included all types of
RCTs and quasi-randomized trials without exclusion due to language, sample size, local aesthetics used or treatment setting. A potential weakness of our review is the exclusion of studies including
participants with deep traumatic wounds or therapeutic incisions,
or comparisons with other non-invasive treatments such as glue,
but our focus was intended to decrease heterogeneity in the review
population.
Two independent review authors extracted and entered data, which
were sent to all participating review authors for confirmation. We
were unable to perform a meta-analysis and we reported most data
descriptively, which is a weakness of our review.
The present review has other sources of potential bias as well.
The primary outcome was participants’ self-report of pain intensity during repair of the wound via validated pain scales. However, a significant number of included trials used observer-reported pain scores or other surrogate outcomes to determine anaesthetic efficacy. Results show non-concordance between participants’ pain scores and ratings by physician, parents and other proxies (Choiniere 1990; Singer 1999; Stephenson 1994). Moreover,
21 of the 25 included RCTs enrolled paediatric participants, and
evaluation of pain in children can be challenging. Researchers have
used several pain scales, including the visual analogue scale (VAS)
and the Faces scale, in a reliable and validated manner among
children as young as five years (Berde 1991; Lander 1993; Zeltzer
1991). Also, evidence supports the validity of tools for measuring
acute pain in children as young as three years old (Tyler 1993).
However, the youngest age at which children can credibly quantify

pain intensity is controversial (Tyler 1993), and behavioural pain
scales for early verbal and preverbal children remain to be validated (Crellin 2007). Therefore, we cannot exclude the possibility
that pain assessment in younger paediatric participants may not
be accurate. Eight studies were not blinded, and four used unclear
blinding strategies.

Agreements and disagreements with other
studies or reviews
We found no disagreement in final study results between any of the
included studies, nor with other previously published studies or
review articles, with the exception of conflicting conclusions about
efficacy from two studies of topical mepivacaine-noradrenaline
(MN) (Smith 1996; Smith 1997a). We could not combine these
two trials because investigators used different pain intensity scales
to determine anaesthetic efficacy, and Smith 1996 did not report
the standard deviations of outcomes. However, all other trials concluded that topical local anaesthetics are at least as effective as
infiltrated ones in laceration repair and provide the advantage of
decreasing the pain of application. An earlier review (Grant 1992)
found that TAC is as effective as lidocaine infiltration in dermal
laceration repair; however, the minimum effective dose remains to
be established to avoid side effects. Throughout subsequent years,
multiple RCTs have reported the same results (see Results section).
With the development of new local anaesthetics, the use of cocaine has been questioned and might be nowadays unjustifiable
by many, as has been found in the included studies (see Results
section).
Our updated version of this review confirms the results of the
previous version (Eidelman 2011).

AUTHORS’ CONCLUSIONS
Implications for practice
Injection of anaesthetics per se induces discomfort and may worsen
’needle anxiety’ among paediatric participants while distorting
the wound site (Kundu 2002). Therefore, topical anaesthetics are
preferable if they do in fact provide similar analgesia to injected local anaesthetics. Individual studies have suggested that some topical formulations may have similar efficacy to conventional local
anaesthetics. However, because of methodological heterogeneity
and lack of high-quality trials, definitive conclusions for clinical
practice cannot be reached at this time.
If cocaine-free topical anaesthetics have similar effectiveness as cocaine-containing agents, then the latter can no longer be justified
in light of their high cost and potential adverse effects. Topical
lidocaine-adrenaline-tetracaine (LAT), which exploits the rapid
onset of lidocaine and the long duration of tetracaine, has been
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the most widely studied cocaine-free formulation. However, additional studies with sound methodological design are necessary
before definitive conclusions for clinical practice can be drawn.
Researchers have reported no serious complications among any
participants treated with cocaine-based or cocaine-free topical
anaesthetics. One mild, self-limiting skin reaction did occur in
one case after application of topical TAC. Nevertheless, clinicians
should exhibit caution and apply topical formulations only as directed, while avoiding mucous membrane contact and following
appropriate dosing regimens.
We have found two new studies published since the time of the
last version of this review. We have added these studies to those
previously included and have updated the analysis. This new analysis yielded the same conclusions as were previously presented.
In conclusion, based mostly on descriptive analysis, we believe
that topical anaesthetics may in fact be an efficacious, non-invasive
means of providing analgesia before suturing of dermal lacerations.
However, data regarding the efficacy of each topical anaesthetic
are based mostly on single comparisons in trials that have unclear
or high risk of bias. Before definitive conclusions can be drawn,
additional methodologically well-designed studies with low risk
of bias are necessary. Future research should focus on the efficacy
of cocaine-free anaesthetics in light of the burden of dispensing
cocaine - a controlled substance that is widely abused.

Implications for research
More investigation is warranted to compare topical lidocaine-adrenaline-tetracaine (LAT) versus other potentially efficacious, cocaine-free topical anaesthetics such as bupivacaine-noradrenaline (BN), prilocaine-phenylephrine (PP) and tetracaine-lidocaine-phenylephrine (TLP). Also, future research could evaluate additional clinically useful topical local anaesthetics or combi-

nations. Recent clinical application of novel formulations of existing local anaesthetics such as microsomal encapsulated bupivacaine (Chahar 2012) or those with an intrinsically long duration
of action such as saxotoxin (Lobo 2015) may expand the range of
available topical local anaesthetics.
Furthermore, additional methodologically sound studies that are
less likely to be flawed by bias or confounding variables are needed.
Many of the included trials did not determine analgesic efficacy by
using validated, participant self-reported pain scales but instead
used observer-reported pain scores or other elementary surrogate
measures. Future trials should adopt uniform outcomes that reflect
participants’ own assessments of procedure-related pain intensity.
Young children and developmentally impaired adults may benefit
most from non-invasive, effective topical anaesthesia before laceration repair. Therefore, validated behavioural pain and distress
scales for preverbal or early verbal children, and for cognitively
impaired adults, will facilitate determination of the efficacy and
safety of topical anaesthetics for these patient subgroups.
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CHARACTERISTICS OF STUDIES

Characteristics of included studies [ordered by study ID]
Anderson 1990
Methods

Single-centre RCT, paediatric emergency department, United States

Participants

151 patients younger than 18 years old with lacerations on the scalp (n = 31), face (n =
79) or extremity (n = 41)

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for 5 to 10 minutes (n = 56)
2. Intradermal infiltration with lidocaine 1% (n = 53)
3. Topical placebo solution, applied for 5 to 10 minutes (n = 42)

Outcomes

1. Before laceration repair, the physician probed the wound with a 25-gauge needle to
determine adequacy of initial anaesthesia.
2. The physician graded participant compliance during the suturing process on a 4point scale (1 - complete compliance, 2 - occasional resistance, 3 - frequent resistance, 4
- continuous resistance).
3. Supplemental lidocaine infiltration was required.
Results of topical TAC versus topical placebo include the following.
1. Adequate initial anaesthesia (topical TAC = 89% vs topical placebo = 17%; P < 0.
0001)
2. Physician compliance scale (1-4) ratings (complete compliance to continuous resistance) (mean score ± SD: topical TAC = 1.25 ± 0.57 vs topical placebo = 1.93 ± 0.96;
P < 0.002)
3. Requirement of supplemental lidocaine infiltration (topical TAC = 18% vs topical
placebo = 83%; P < 0.0001)
Results of topical TAC versus infiltrated local anaesthetic include the following.
1. Adequate initial anaesthesia (topical TAC = 89% vs infiltrated local anaesthetic =
79%; P = non-significant)
2. Physician compliance scale (1-4) ratings (complete compliance to continuous resistance) (mean score ± SD: topical TAC = 1.25 ± 0.57 vs infiltrated local anaesthetic = 1.
94 ± 1.12; P < 0.002)
3. Requirement of supplemental lidocaine infiltration (topical TAC = 18% vs infiltrated
local anaesthetic = 23%; P = non-significant)

Intervention dates

August 1986 to May 1987

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
Bias

Authors’ judgement
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Anderson 1990

(Continued)

Random sequence generation (selection High risk
bias)

Quote: ”The last digit of the patient’s medical record number was used to enter patients into either the intradermal or topical
group“
Comment: probably not done

Allocation concealment (selection bias)

High risk

Quote: ”The last digit of the patient’s medical record number was used to enter patients into either the intradermal or topical
group“
Comment: probably not done

Blinding (performance bias and detection High risk
bias)
All outcomes

Quote: ”Individual study vials containing
5ml of TAC or placebo were prepared in the
pharmacy of University of Massachusetts
Medical Center following a standard protocol and assigned numbers“; ”The ED staff
member evaluating and suturing the patient were blind to the solution contained
in the vials“
Comment: Comparisons of topical TAC
and topical placebo were probably blinded.
However, comparisons between lidocaine
infiltration and topical TAC were probably
unblinded

Incomplete outcome data (attrition bias)
All outcomes

Low risk

153 eligible patients, 2 refused to participate. 151 randomized, no missing outcome
data

selective reporting of outcomes
All outcomes

Unclear risk

All outcomes discussed in Methods section reported in Results. Subgroup analysis based on location of laceration was not
prespecified

Other bias (sample size)

High risk

56 TAC:
53 lidocaine
42 placebo

Blackburn 1995
Methods

Single-centre RCT, emergency department, community-based teaching hospital, United
States

Participants

35 adult and paediatric patients (minimum age of 2 years) with facial and scalp lacerations, ≤ 6 cm in length
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Blackburn 1995

(Continued)

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 10.4%), applied
for 20 minutes (n = 18)
2. Topical TLE solution (lidocaine 5% and epinephrine 1:2000), applied for 20 minutes
(n = 17)

Outcomes

1. The participant reported discomfort using a facial effective pain scale (1-9), which
consisted of 9 faces with various emotional expressions. However, in a few cases, the
participant was too young to use the pain scale, so the physician estimated the participant’s
pain using the same Faces scale. The study combined self-reported and surrogate Faces
pain scale scores in the final results.
2. Rescue lidocaine infiltration was required.
3. The study reported any acute adverse reactions directly related to the anaesthetic
Results included the following.
1. Faces pain scale (1-9) scores (mean score ± SD: topical TLE = 3.29 ± 1.92 vs topical
TAC = 2.66 ± 1.78; P = 0.33)
2. Requirement for supplemental lidocaine infiltration (topical TLE = 6% vs topical
TAC = 6%; P = not reported)
3. No acute anaesthetic-related adverse effects

Intervention dates

May to August 1992

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”The TAC and TLE solutions were
arbitrarily assigned to a single-dose (10ml)
, sequentially numbered vials by the pharmacist. The vials, with the specific contents
unknown to the emergency physician, were
forwarded to the ED as requested“
Comment: probably not done

Allocation concealment (selection bias)

Low risk

Quote: ”The solutions were made visibly
identical by adding methylene blue to the
TLE solution so that it matched the intrinsic blue colour of TAC“
”The vials, with the specific contents unknown to the emergency physician, were
forwarded to the ED as requested“
Comment: probably done

Blinding (performance bias and detection Low risk
bias)

Quote: ”The solutions were made visibly
identical by adding methylene blue to the
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Blackburn 1995

(Continued)

All outcomes

TLE solution so that it matched the intrinsic blue colour of TAC“
Comment: probably done

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

35 participants in study but reporting of
attrition or exclusions insufficient to permit
judgement

selective reporting of outcomes
All outcomes

Low risk

All outcomes described in Methods were
fully reported in Results section. Adverse
events noted

Other bias (sample size)

High risk

Total N = 35:
17 participants in the TLE group; 18 in the
TAC group

Bonadio 1990
Methods

Single-centre RCT, Department of Emergency Medicine, Children’s Hospital Wisconsin,
Milwaukee, Wisconsin, United States

Participants

55 paediatric patients with facial lacerations

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for 10 to 15 minutes (n = 24)
2. Topical AC solution (epinephrine 1:2000, cocaine 11.8%), applied for 10 to 15
minutes (n = 31)

Outcomes

1. The physician calculated the total number of ’sutures eliciting pain’ using the following system. Each suture placed involved 2 points; an entrance and an exit piercing of
the wound tissue with the needle. A painful response consisted of a verbal participant
experiencing a painful sensation or a non-verbal participant beginning to cry, or crying
with greater intensity. The total number of ’sutures placed eliciting pain’ was calculated
by dividing the total number of painful responses by 2.
2. The study reported any acute adverse effects due to the anaesthetic
Results included the following.
1. The physician calculated the total number of ’sutures eliciting pain’ (topical AC = 7/
103 (4%) vs topical TAC = 7/151 (7%); P = not-reported).
2. No acute anaesthetic-related adverse effects were noted.

Intervention dates

Not reported

Declaration of interest

No explicit documentation regarding conflicts of interest.

Notes

Source of funding: general academic paediatric development fellowship from The Robert
Wood Johnson Foundation; and Grant 10066 from The Robert Wood Foundation
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Bonadio 1990

(Continued)

Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”...as in each case an assistant randomly selected one of the two solutions for
physician application...“
Comment: probably not done

Allocation concealment (selection bias)

Quote: ”an assistant randomly selected one
of the two solutions for physician application...“
Comment: probably not done

High risk

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”The managing physician was
’blind’ to which preparation was being administered...the physician was informed of
the solution composition only after the suturing procedure and pain scoring were
completed“
Comment: probably done, assuming the 2
solutions were visually identical

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

55 participants in study but reporting of
attrition or exclusions insufficient to permit
judgement

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported in the prespecified way

Other bias (sample size)

High risk

55 paediatric participants:
1. Topical TAC solution, n = 24
2. Topical AC solution, n = 31

Ernst 1990
Methods

RCT, single centre, emergency department, United States

Participants

139 adult and paediatric patients older than 5 years of age, with laceration of the face (n
= 53), scalp (n = 33), extremity (n = 52) or trunk (n = 1), measuring < 5 cm in length

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for 5 to 10 minutes (n = 69)
2. Topical cocaine solution 11.8%, applied for 5 to 10 minutes (n = 70)

Outcomes

1. The physician assessed the adequacy of initial anaesthesia by pricking the wound
with a pin. If pain was elicited with pinprick, then 1% lidocaine was infiltrated, and the
participant was assigned to the ’poor anaesthesia’ group.
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Ernst 1990

(Continued)
2. Among participants who did not require infiltrated lidocaine, the physician rated the
effectiveness of anaesthesia during suturing on a numerical scale (0-10)
3. Investigators reported acute adverse reactions directly related to the anaesthetic
Results include the following.
1. Incidence of ’poor anaesthesia’ (topical cocaine = 20% vs topical TAC = 12%; P = not
reported)
2. Physician rating of anaesthetic effectiveness on a numerical scale (0-10; least effective
to most effective) (mean scores ± SD: topical cocaine = 6.44 ± 3.48 vs topical TAC = 7.
74 ± 3.03; P = 0.005)
3. No acute anaesthetic-related adverse effects

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Source of funding: Saint Francis Hospital and Medical Center
Study author contacted for additional information but did not reply

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”TAC and cocaine solutions were
randomly distributed with only a number
from 1-150 appearing on each vial“
Comment: unclear; exact mechanism of
randomization not described

Allocation concealment (selection bias)

Quote: ”TAC and cocaine solutions were
randomly distributed with only a number
from 1-150 appearing on each vial“
”The investigator was blinded as to the
identity of the agent. The code was kept
in the pharmacy and was available to the
investigators only in case of emergency“
Comment: unclear; allocation concealment possible if a pharmacy-controlled
randomization process was used. However,
this is not explicitly reported, so we decided
upon unclear risk

Unclear risk

Blinding (performance bias and detection Low risk
bias)
All outcomes
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Ernst 1990

(Continued)

Incomplete outcome data (attrition bias)
All outcomes

Low risk

148 participants were enrolled and 9 were
excluded from the study before unblinding and analysis (4 improper application, 4
participant younger than 5 years and one
with laceration too large). We concluded
low risk of bias because the number of excluded participants was balanced between
the 2 interventions, and reasons for exclusion are unlikely to be related to pain scores
during suturing

selective reporting of outcomes
All outcomes

Unclear risk

All outcomes described in Methods section
were reported in Results. Subgroup analyses by site and age were not prespecified

Other bias (sample size)

Unclear risk

Total N = 139:
70 in the cocaine-treated group
69 in the TAC-treated group

Ernst 1995a
Methods

Single-centre RCT, Department of Medicine, Section of Emergency Medicine, Louisiana
State University, New Orleans, Louisiana, United States

Participants

95 patients age 5 to 17 years with lacerations on the face (n = 64) or scalp (n = 31), ≤ 7
cm in length

Interventions

1. Topical LAT gel (lidocaine 4%, epinephrine 1:2000, tetracaine 0.5%), applied for 10
to 30 minutes (n = 48)
2. Topical TAC gel (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied for
10 to 30 minutes (n = 47)

Outcomes

1. Participant-rated modified multi-dimensional pain scale (0-10)
2. Physician-rated modified multi-dimensional pain scale (0-10)
3. Percentage of sutures causing pain
4. Requirement of supplemental lidocaine infiltration
5. Acute adverse reactions directly related to the anaesthetic reported by investigators
Results include the following.
1. Participant-reported modified multi-dimensional pain scale (0-10) scores (mean
ranked sum: topical LAT = 49.0 vs topical TAC = 46.9; P = 0.71)
2. Physician-assigned multi-dimensional pain scale (0-10) scores (mean ranked sum:
topical LAT = 48.7 vs topical TAC = 47.3; P = 0.80)
3. Percentage of sutures placed causing pain (mean ranked sum: topical LET = 49.57 vs
topical TAC = 46.39; P = 0.51)
4. Requirement of supplemental lidocaine infiltration (topical LET = 4%, topical TAC
= 6%; P = not reported)
5. No acute anaesthetic-related adverse effects
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Ernst 1995a

(Continued)

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Funding not reported
-Study author contacted for additional information but did not reply

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Low risk
bias)

Quote: ”Gels were randomized according
to a random numbers table“
Comment: probably done

Allocation concealment (selection bias)

Quote: ”randomized according to a random numbers table“
Comment: probably not done

High risk

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”Patients and physicians performing suturing were blinded to which gels
were being used. Only the numbers 1-100
appeared on the capped syringes“
Comment: probably done, assuming the 2
gels were visually identical

Incomplete outcome data (attrition bias)
All outcomes

Low risk

100 participants entered into the trial, but
5 were excluded before statistical analysis because topical anaesthesia was inadequate and lidocaine infiltration was required. Two participants in the LAT group
and 3 in the TAC group were excluded. We
judged low risk of bias because the number
of excluded participants was balanced between the 2 interventions

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were reported: Physicians and participants or parents rated anaesthesia effectiveness during
suturing utilizing a modified multi-dimensional pain scale
Prespecified secondary outcomes were also
reported: Participants or parents reported
the number of sutures causing pain, which
was analysed as percent of total sutures
placed
Quote: “Both physician and patient or parent rated the anaesthesia effectiveness dur-
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Ernst 1995a

(Continued)
ing suturing utilizing a modified multidimensional pain scale…. Patients or parents reported the number of sutures causing pain, which was analysed as percent of
total sutures placed”
Table 1 lists demographics (age, sex),
wound size, location, amount of anaesthetic used and number of sutures placed
Table 2 reports percent of sutures causing
pain in each topical anaesthesia group
Table 3 reports physician vs participant rating for pain scores for each topical anaesthesia group

Other bias (sample size)

High risk

LAT GEL = 48 participants
TAC gel = 47 participants

Ernst 1995b
Methods

Single-centre RCT, Department of Medicine, Section of Emergency Medicine, Louisiana
State University, New Orleans, Louisiana, United States

Participants

95 adult patients with laceration of the face (n = 81) or scalp (n = 13) ≤ 7 cm in length

Interventions

1. Topical LAT solution (lidocaine 4%, epinephrine 1:2000, tetracaine 0.5%), applied
for 10-30 minutes (n = 48)
2. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for 10-30 minutes (n = 47)

Outcomes

1. Participant-rated VAS (100 mm) pain score
2. Physician-rated VAS (100 mm) pain score
3. Percentage of sutures eliciting pain
Results include the following.
1. Participant-reported VAS (100 mm) pain scores (mean ranked sum: topical LET =
45.3 vs topical TAC = 50.8; P = 0.27)
2. Physician-reported VAS scores (mean ranked sum: topical LAT = 41.6 vs topical TAC
= 54.6; P = 0.01)
3. Percentage of sutures causing pain (mean ranked sum: topical LET = 42.8% vs topical
TAC = 53.3%; P = 0.36)

Intervention dates
Declaration of interest

Not reported

Notes

Funding resource: supported by a grant from the Louisiana State University Emergency
Medicine Residency Grant Fund
Study author contacted for additional information but did not reply
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Ernst 1995b

(Continued)

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Low risk
bias)

Quote: ”Solutions were randomized according to a random numbers table“
Comment: probably done

Allocation concealment (selection bias)

Low risk

Quote: ”The solutions were prepared by
a pharmacist and were available in coded
sterile, capped 3ml syringes“
”Both TAC and LAT were clear solutions.
..“
”Patients and physicians performing
wound closure were blinded“
Comment: probably done

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”The solutions were prepared by
a pharmacist and were available in coded
sterile, capped 3ml syringes with a cotton
ball for application“
”Both TAC and LAT were clear solutions
mixed from powders“.
”Patients and physicians performing
wound closure were blinded“
Comment: probably done

Incomplete outcome data (attrition bias)
All outcomes

High risk

100 total participants enrolled but only 95
were included in final data analysis. Four
participants were excluded because they required additional injected lidocaine (1 LAT
group, 3 in TAC group), and 1 because of
improper data collection. We judged ’no’
(high risk of bias) because requirement of
additional lidocaine is directly related to
pain intensity during laceration repair

selective reporting of outcomes
All outcomes

Low risk

All outcomes described in Methods reported fully in Results. Adverse events reported

Other bias (sample size)

Unclear risk

47 receiving TAC and 48 receiving LAT.
Total N = 95
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Ernst 1997
Methods

Single-centre RCT, urban emergency department, United States

Participants

66 paediatric and adult patients, older than 5 years of age with laceration on the face (n
= 30), scalp (n = 10) or extremity (n = 24), 1.5 to 10 cm in length

Interventions

1. Topical LAT gel (lidocaine 4%, epinephrine 1:2000, tetracaine 0.5%), applied for 10
to 20 minutes (n = 33)
2. Intradermal infiltration with lidocaine 1%, epinephrine, buffered with 8.4%
NaHCO3 (n = 33)

Outcomes

1. Participant-rated VAS (100 mm) pain scale scores
2. Physician-rated VAS (100 mm) pain scale scores
3. Requirement of supplemental lidocaine infiltration
4. Percentage of sutures placed eliciting pain
Results included the following.
1. Participant self-reported VAS (100 mm) pain scores (median values (interquartile
range): topical LAT = 0 (0-1.35) vs infiltrated local anaesthetic = 0 (0-0.6); P = 0.48,
standard deviations not reported)
2. Physician-reported VAS (100 mm) pain scores (median values (interquartile range):
topical LAT = 0 (0-0.55) vs infiltrated local anaesthetic = 0 (0-0.35); P = 0.83, standard
deviations not reported)
3. Percentage of sutures causing pain (topical LAT = 13% vs infiltrated local anaesthetic
= 6%; P = 0.28)
4. Requirement of supplemental infiltrated anaesthesia (LAT = 6% vs infiltrated anaesthetic = 0%; P = not reported)

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Funding not reported
Study author contacted for additional information but did not reply

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Low risk
bias)

Quote: ”The doses of anaesthetic were
numbered 1-66 according to a computer
generated random table of numbers prepared before the study“
Comment: probably done

Allocation concealment (selection bias)

Quote: ”physicians and patients were not
blinded to the form of anaesthesia“
Comment: probably not done

High risk
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Ernst 1997

(Continued)

Blinding (performance bias and detection High risk
bias)
All outcomes

Quote: ”Because of the obvious differences
in form and application, physicians and
patients were not blinded to the form of
anaesthesia“
Comment: probably not done

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

66 participants included in study but reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were reported: Participant and physician ranked
pain of suturing with validated linear visual
analogue scale
Prespecified secondary outcomes were also
reported: Necessity for additional lidocaine and treatment success or failure were
recorded at the time of the procedure
Quote: “The primary endpoints were patient and physician perception of application or injection pain and anaesthesia effectiveness…. Patients and physicians ranked
the pain of injection or application and
the pain of suturing using a previously validated linear visual analog scale so that
each laceration had four associated measurements of pain”
Quote: “The length of the laceration, location, length of time anaesthesia lasted,
amount of anaesthesia used, necessity for
additional lidocaine, and treatment success
or failure were recorded at the time of the
procedure, along with any complications”
Table 1 lists demographics (age, sex),
wound size, initial amount of anaesthesia,
need for more anaesthesia and location
Table 2 reports physician and participant
ratings of pain of local and topical anaesthetic application (VAS) - effectiveness
Table 3 reports physician vs participant rating for pain scores of suturing (VAS)
Table 4 reports percent of sutures causing
pain per participant

Other bias (sample size)

High risk

Quote: “66 subjects were entered in the
study. Topical LAT = 33, infiltrated lidocaine = 33”
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Gaufberg 2007
Methods

Single-centre RCT, community teaching hospital emergency department, United States

Participants

100 adult patients older than 18 years of age with lacerations involving scalp (n = 15)
, face (n = 15), lower extremity (n = 13), upper extremity (n = 15) or hands (n = 42)
Laceration length ranged from < 1 cm to > 5 cm

Interventions

1. Topical LE solution (lidocaine 5%, epinephrine 0.025%), applied for 10 to 15 minutes
for 1 to 4 sequential layered applications (n = 50)
2. Intradermal infiltration with lidocaine (n = 50)

Outcomes

1. Participant-rated VAS (100 mm) pain scale scores
2. Amount of lidocaine required (mg)
3. Number of applications of topical anaesthetic
4. Difficulty with wound healing or infection
Results included the following.
1. Participant-reported VAS (100 mm) pain scores (mean score ± SD: topical TLE = 0.
16 ± 0.46 vs infiltrated lidocaine = 0.20 ± 0.49; P = 0.59)
2. Amount of lidocaine required (mean score: TLE = 135 mg vs infiltrated lidocaine =
124 mg; P = 0.90, SD not reported)
3. Number of anaesthetic applications of TLE (mean score = 2.7; 2 participants (4%)
required 1 layer, 17 (34%) required 2 layers, 26 (52%) required 3 layers, 5 (10%) required
4 layers)
4. No participants had poor wound healing or infection.

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”We performed a prospective, randomized controlled trial..“
Comment: unclear; study reported to be
randomized but method of sequence generation not described

Allocation concealment (selection bias)

Comment: probably not done. Interventions of topical anaesthesia vs infiltrated
anaesthesia are visually different. No mechanism used to conceal the intervention
from participants or study personnel was
described

High risk

Topical anaesthetics for pain control during repair of dermal laceration (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

43

Gaufberg 2007

(Continued)

Blinding (performance bias and detection High risk
bias)
All outcomes

Quote: ”100 patient[s] were enrolled in a
randomized controlled trial...“
Comment: probably not done, as study did
not report blinding and compared topical
vs infiltrated forms of anaesthesia

Incomplete outcome data (attrition bias)
All outcomes

Low risk

100 enrolled participants in study, no missing outcome data or exclusions

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were reported: patient-reported VAS pain scores
Prespecified secondary outcomes were also
reported: amount of lidocaine required,
number of applications of topical anaesthetic and difficulty with wound healing
Quote: “The effectiveness of anaesthesia
was assessed by the patient immediately after the procedure using a 1-10 visual analog pain scale administered by a third-party.
The subject was instructed to assess the
pain from application or anaesthesia, and
the pain from suturing the wound”
Table 2. Application of anaesthesia
Table 3. Pain during application of anaesthetic
Table 4. Effectiveness of anaesthesia during
wound repair
Table 5. Follow-up interview after wound
repair for 79 participants

Other bias (sample size)

Unclear risk

Infiltrated lidocaine = 50 participants
Topical TLE = 50 participants

Hegenbarth 1990
Methods

Two-centre RCT, emergency departments, Uunited States

Participants

467 patients, 18 years of age or younger, with dermal lacerations on the face, scalp,
extremity and trunk

Interventions

1. TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%),
applied for 30 minutes (n = 262)
2. Intradermal infiltration with lidocaine 1% (n = 205)

Outcomes

Pain during the suturing process was not directly assessed.
1. Before laceration repair, the physician probed the wound with a 26-gauge needle to
determine adequacy of initial anaesthesia (adequate, inadequate or unable to access).
The physician administered infiltrated anaesthetic to participants in the TAC group with
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Hegenbarth 1990

(Continued)
’inadequate’ anaesthesia.
2. Investigators reported any acute adverse reactions to the anaesthetic
Results include the following.
1. Adequate initial anaesthesia for facial and scalp lacerations (topical TAC = 81% vs
infiltrated local anaesthetic = 87%; P = 0.005). Adequate initial anaesthesia for the
extremity and trunk wound group (topical TAC = 43% vs infiltrated local anaesthetic =
89%; P < 0.0001)
2. No acute anaesthetic-related adverse effects

Intervention dates

December 1986 to November 1987

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”Randomization of anaesthetic
treatment was determined by the final digit
of the patients medical record number, with
odd numbers receiving lidocaine and even
numbers receiving TAC“
Comment: probably not done

Allocation concealment (selection bias)

High risk

Quote: ”Randomization of anaesthetic
treatment was determined by the final digit
of the patient’s medical record number“
”unblinded study“
Comment: probably not done

Blinding (performance bias and detection High risk
bias)
All outcomes

Quote: ”We conducted a prospective, randomized, unblinded study...“
Comment: probably not done

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

467 participants included in the study but
reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

All outcomes described in Methods section
were fully reported in Results, including
subgroup analyses by area of laceration

Other bias (sample size)

Low risk

262 children received TAC (218 facial or
scalp and 44 extremity or trunk wounds)
, and 205 received lidocaine (158 facial or
scalp and 47 extremity or trunk wounds)
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Jenkins 2014
Methods

RCT, single-centre, hospital emergency department, Northern Ireland

Participants

110 (54 topical anaesthetic putty, 56 lidocaine infiltration), median age (range): infiltration 35 (18-84), topical anaesthetic putty 35 (20-81)
Male: 94 (85.5%), female: 16 (14.5%). Topical anaesthetic putty group had 10 F, 44 M;
lidocaine infiltration group had 6 F, 50 M
Wounds: < 8 cm long and needing suturing or stapling

Interventions

1. Topical anaesthetic putty (containing 4.94% w/w lidocaine hydrochloride,
equivalent to 4% w/w lidocaine base)
2. Lidocaine infiltration (1% w/v)

Outcomes

Primary outcomes:
Participant-reported 0-10 VAS during sensory testing with a 21-gauge needle “directly
after treatment”. Mean pain score was 0.78 + 1.12 (SD) after lidocaine infiltration, 1.49
+ 1.76 after topical anaesthetic putty. Overlapping 1-sided 95% CI limits plus (because
data were not normally distributed) non-parametric contrasting of median scores; both
showed non-inferiority of topical anaesthetic putty c/w infiltrated lidocaine
Secondary outcomes:
Need for rescue anaesthesia (required by 3 in infiltration group and 4 in topical anaesthetic
putty group), “wound evaluation score” obtained 7-10 days after treatment (12 in topical
anaesthetic putty group had less than perfect scores vs 5 in infiltration group), presence
of wound infection (4 in infiltration group vs 2 in topical anaesthetic putty group),
dehiscence (2 in topical anaesthetic putty group) and adverse effects (1 inflamed wound
in topical anaesthetic putty group, 1 required resuturing in each group)
No anaesthetic toxicity reported

Intervention dates

Not reported

Declaration of interest

The wound putty used in this study was not a proprietary product and was not produced
commercially. The putty was manufactured by 2 of the study authors - Drs. Murphy and
McCarron. After the success of this trial, Drs. Jenkins and McCarron sought to protect
certain aspects of the putty formulation in both the United States and Europe. This
patent application was pending at the time of publication and was related to a certain
aspect of the formulation that enables lidocaine to be included
The authors of this study received no funding from commercial sources to support the
study. Funding for this study was obtained through a peer-reviewed competitive process
from the Public Health Agency in Northern Ireland
Drs. Jenkins and McCarron were pursuing sources of capital to commercialise the putty
but had not yet secured this funding

Notes

Sourse of funding: supported by the Research and Development Office (Northern Ireland) Trauma and Rehabilitation Recognised Research Group (RRG 8.46 RRG/3273/
06)
Rescue medication: no systemic anaesthesia or analgesia mentioned. However, “The
decision to offer or use rescue anaesthesia rested with the treating investigator”. Rescue =
wound margin infiltration with a further dose of 1% lidocaine for the 7 (4 in the topical
anaesthetic putty group, 3 in the lidocaine infiltration group) who received it
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(Continued)

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Low risk
bias)

Randomization sequence generated by Microsoft Excel version 14.3.9 through a
permuted block randomization technique,
with a block size of 8

Allocation concealment (selection bias)

Randomization sequence provided in
opaque, serially numbered envelopes

Low risk

Blinding (performance bias and detection High risk
bias)
All outcomes

Open label
Quote: “Because of the nature of the treatment, it was not feasible to blind either the
participants or the investigators to the treatment received“
[Extractor’s note: not necessarily true,
could have used placebo infiltration and
placebo topical putty]

Incomplete outcome data (attrition bias)
All outcomes

Low risk

All participants completed the first, acute
part of the study; 19 did not complete the
follow-up wound assessment

selective reporting of outcomes
All outcomes

Low risk

All outcome-related data collected during
the acute phase were complete

Other bias (sample size)

Unclear risk

54 topical anaesthetic putty
56 lidocaine infiltration

Kendall 1996
Methods

Single-centre RCT, Accident and Emergency Department of Gloucestershire Royal Hospital, United Kingdom

Participants

107 paediatric patients, 3-16 years old, with lacerations < 4 cm in length, located anywhere on the body except mucous membranes or digits

Interventions

1. Topical AC solution (epinephrine 1:2000, cocaine 4.7%), applied for 10-15 minutes
(n = 51)
2. Intradermal infiltration with lidocaine 1% (n = 51)

Outcomes

1. Children younger than 10 years of age rated pain during both laceration repair and
anaesthetic application using the Wong-Baker Faces Scale. Patients 10 years of age or older
used a VAS (10 cm) score to rate pain during suturing and anaesthetic administration.
2. Physician-rated VAS (10 cm) pain scale scores
3. Parent-rated VAS (10 cm) pain scale scores
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Kendall 1996

(Continued)
4. Parent rated overall acceptability of the procedure.
5. Study reported any acute adverse effects to the anaesthetic
Results include the following.
(standard deviations not reported)
1. Participant-rated pain scores (pooled VAS and Wong-Baker Faces scores) (mean score:
topical AC = 4.50 vs infiltrated local anaesthetic = 4.40; P = NS)
2. Physician-rated VAS (10 cm) pain scale scores (mean score: topical AC = 2.60 vs
infiltrated local anaesthetic = 3.60; P = NS)
3. Parent-rated VAS (10 cm) pain scale scores (mean score: topical AC = 3.10 vs infiltrated
local anaesthetic = 3.80; P = NS)
4. Parent rating of overall acceptability of the procedure (topical AC = 14.5% unacceptable vs infiltrated local anaesthetic = 39% unacceptable; P < 0.01)
5. No acute anaesthetic-related adverse effects

Intervention dates

January to November 1994

Declaration of interest

No explicit documentation regarding conflicts of interest

Notes

No sources of funding mentioned

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”Children presenting with an appropriate laceration were consecutively assigned to receive either conventional intradermal lignocaine or topical AC preparation“
Comment: probably not done

Allocation concealment (selection bias)

High risk

Quote: ”consecutively assigned to receive
either conventional intradermal lignocaine
or topical AC preparation“
”Groups could not be blinded“.
Comment: probably not done

Blinding (performance bias and detection High risk
bias)
All outcomes

Quote: ”The nature of the trial meant that
the two groups could not be blinded“
Comment: probably not done

Incomplete outcome data (attrition bias)
All outcomes

120 participants were enrolled but 13 were
excluded before data analysis (incomplete
data collection for 8, 2 received Steristrips
and not sutures, 3 did not attend followup). We concluded low risk of bias because
reasons for exclusion were unlikely to be related to pain scores during laceration repair

Low risk
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Kendall 1996

(Continued)

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported in the prespecified way

Other bias (sample size)

Unclear risk

1. Topical AC solution, n = 56
2. Intradermal infiltration with lidocaine,
n = 51

Krief 2002
Methods

RCT (unclear if single centre or multi-centre)

Participants

41 adult and paediatric patients, 5 to 23 years of age, with simple lacerations < 5 cm in
length

Interventions

1. Topical LET gel (lidocaine, epinephrine, tetracaine), applied for 60 minutes (n = 22)
2. EMLA cream (lidocaine 2.5%, prilocaine 2.5%), applied for 60 minutes (n = 19)

Outcomes

1. Participant-rated VAS (100 mm) pain scale scores
2. Legal guardian-rated VAS (100 mm) pain scale scores (when applicable)
3. Physician-rated VAS (100 mm) pain scale scores
4. Requirement of supplemental lidocaine infiltration
Pain scores were obtained at 4 points in time: after irrigation, first suture or staple placement, last suture or staple placement and during supplemental infiltration of lidocaine
(if applicable)
Results include the following.
1. Participant self-reported VAS (100 mm) pain scores were not significantly different
between the 2 anaesthetic groups (mean pain scores not provided; P > 0.05)
2. Legal guardian-reported VAS (100 mm) pain scores were not significantly different
between the 2 groups (mean pain scores not provided; P > 0.05)
3. Physician-reported VAS (100 mm) pain scores were greater in the EMLA group during
irrigation (mean VAS EMLA = 21.4 mm vs LET gel = 10.1 mm; P = 0.3) and during
first suture/staple placement (mean VAS EMLA = 41.7 mm vs LET gel = 14.0 mm; P =
0.004)
4. Requirement of supplemental infiltrated anaesthesia: 13/19 participants in the EMLA
group required infiltrated lidocaine (68%) compared with 5/22 in the LET group (23%)
(P = 0.005%)

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Trial published as an abstract only. Source of funding not reported

Risk of bias
Bias

Authors’ judgement
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Krief 2002

(Continued)

Random sequence generation (selection Unclear risk
bias)

Quote: ”We conducted a double-blind,
randomized trial...“.
Comment: unclear, as method of sequence
generation not described

Allocation concealment (selection bias)

Comment: unclear

Unclear risk

Blinding (performance bias and detection Unclear risk
bias)
All outcomes

Quote: ”We conducted a double-blind,
randomized trial...“
Comment: unclear, as reported to be double-blind but no details provided

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

41 participants included in the study but
reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported

Other bias (sample size)

High risk

41 participants:
1. Topical LET gel, n = 22
2. EMLA cream, n = 19

Kuhn 1996
Methods

Single-centre (2 hospitals) RCT, emergency departments of 2 tertiary referral hospitals
(1 paediatric), Adelaide South Australia

Participants

180 adult and paediatric patients, 6 years of age or older, with lacerations 3-7 cm in
length, located on the head (n = 114) or extremity (n = 66)

Interventions

1. Topical MAC solution (bupivacaine 0.5%, epinephrine 1:2000, cocaine 10.0%),
applied for at least 10 to 15 minutes for head lacerations and for 30 minutes for extremity
wounds (n = 92)
2. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 10.0%), applied
for at least 10 to 15 minutes for head lacerations and for 30 minutes for extremity wounds
(n = 88)

Outcomes

1. Children younger than 12 years of age rated pain during laceration repair using the
Wong-Baker Faces scale.
2. Participants 12 years of age or older used a VAS (10 cm) score to rate pain during
suturing.
3. The physician assessed the effectiveness of initial anaesthesia using pinprick.
4. Participants noted their preference for topical anaesthesia in the future.
5. Investigators reported any acute adverse effects to the anaesthetic
Results include the following.
1. Children younger than 12 years of age used the Wong-Baker Faces Scale (1-9) (mean
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(Continued)
score ± SD: topical MAC = 2.35 ± .50 vs topical TAC = 2.46 ± 2.34; P = 0.96).
2. Participants 12 years of age or older used the VAS (100 mm) pain scale (mean score
± SD: topical MAC = 6.9 ± 10.9 vs topical TAC = 12.0 ± 14.5; P = 0.16)
3. Adequacy of initial anaesthesia (topical MAC = 73% vs topical TAC = 74%; P = 0.
87)
4. Participants’ preference for topical anaesthesia in the future (topical MAC = 77% vs
topical TAC = 81%; P = 0.42)
5. No acute anaesthetic-related adverse effects

Intervention dates

Feburary 1992 to April 1994

Declaration of interest

No explicit documentation regarding conflicts of interest

Notes

Source of funding: grant from Society of Hospital Pharmacists of Australia

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”The study was a double-blinded,
randomized, prospective trial..“
Comment: unclear, as study reported to be
randomized but method of sequence generation was not described

Allocation concealment (selection bias)

Low risk

Quote: ”Solutions of MAC and modified
TAC were prepared and placed in syringes
marked A or B by a pharmacist not involved
in study. All study participants remained
blinded throughout the trial“
Comment: probably done, assuming solutions were visually identical

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”Solutions of MAC and modified
TAC were prepared and placed in syringes
marked A or B by a pharmacist not involved
in study. All study participants remained
blinded throughout the trial“
Comment: probably done, assuming solutions were visually identical

Incomplete outcome data (attrition bias)
All outcomes

191 participants were enrolled but 10 were
excluded before data analysis (5 younger
than 6 years of age, 2 had wounds greater
than 5 mm deep, 2 were not sutured, 1 had
a digital laceration). We concluded low risk
of bias because reasons for exclusion were
unlikely to be related to pain scores during
laceration repair

Low risk
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(Continued)

selective reporting of outcomes
All outcomes

Unclear risk

The study protocol did not describe prespecified outcomes.

Other bias (sample size)

Unclear risk

180 participants:
1. Topical MAC solution, n = 92
2. Topical TAC solution, n = 88

Lee 2013
Methods

Single-centre RCT, Department of Emergency Medicine, Singapore General Hospital

Participants

n = 40, > 1 year to 70 years (only 1 patient > 10 years old was included in the study), 29
males (72.5%), 11 females (27.5%). Length of the wounds was 3.1 cm for the LG group
and 3.5 cm for the LI group. Depth of the wounds was 0.5 cm and 0.57 cm, respectively

Interventions

1. LAT gel (n = 23): mean length of wound/cm (SE) 3.1 cm (SE 0.31). Mean depth of
wound/cm (SE) 0.5 (0.07). Location of wound: head 17/23 (74.0%), trunk 0/23 (0%)
and limb 6/23 (26%)
2. Infiltrated lidocaine (n = 17): mean length of wound/cm (SE) 3.5 cm (SE 0.36). Mean
depth of wound/cm (SE) 0.57(0.08). Location of wound: head 11/17 (64.7%), trunk
0/17 (0%) and limb 6/17 (35.3%)

Outcomes

1. LAT gel:
a. Efficacy: 10 cm VAS pain score by participant (mean ± SE) = 2.5 (0.52)
b. Pain during application (mean ± SE): 1.5 (0.40)
Pain score by parents, clinician or participants younger than 10 years old; results not
provided
2. Lignocaine infiltration:
a. Efficacy: 10 cm VAS pain score by participant (mean ± SE) = 2.6 (0.58)
b. Pain during application (mean ± SE): 3.5 (0.46)
Pain score by parents, clinician or participants younger than 10 years old; results not
provided
Complications:
1. No acute anaesthetic complications in either group
2. One week later, assessed for wound complications
1. LAT gel (study lists 25 but probably typographical error because only 23 participants
in this treatment arm)
a. Wound Infection, 5/25 (5/23?)
b. Wound dehiscence = 1/25 (1/23?)
c. Stitches lost = 1/25 (1/23?)
2. Lignocaine infiltration
a. Wound Infection, 2/14
b. Wound dehiscence, 0/14
c. Stitches lost, 0/14

Intervention dates

Janurary to April 2003

Declaration of interest

None.
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(Continued)

Notes

Souce of funding: none

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Suitable participants were assigned to 2
arms of treatment via sealed envelopes.
However, precise method of sequence generation was not described

Allocation concealment (selection bias)

Use of assigned envelopes described but information proved insufficient to allow a decision between low risk and high risk

Unclear risk

Blinding (performance bias and detection High risk
bias)
All outcomes

Not blinded and outcome could be affected
by lack of blinding

Incomplete outcome data (attrition bias)
All outcomes

Low risk

40 patients recruited and no drop-outs
mentioned

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were reported.

Other bias (sample size)

High risk

LAT gel = 23 participants
Infiltrated lidocaine = 17 participants

Pryor 1980
Methods

Single-centre RCT, Army Medical Center emergency department, United States

Participants

158 adult and paediatric patients, range 10 months to 53 years old (mean = 9 years old)

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for minimum of 10 minutes
(n = 82)
2. Intradermal infiltration with lidocaine (n = 76)

Outcomes

1. Participants 10 years of age or older rated anaesthetic efficacy (complete, partial or
none) depending on whether they experienced pain during laceration repair.
2. Also, after completion of wound repair, participant or parent rated anaesthetic acceptability (excellent, good or poor)
Results include the following.
1. Verbal rating (complete, partial or none) of anaesthetic efficacy (complete: topical
TAC = 84% vs infiltrated local anaesthetic = 88%; P = not reported)
2. Anaesthetic acceptability: Participants 17 years of age and younger preferred topical
TAC (P < 0.005); no difference between the 2 anaesthetic groups among participants
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(Continued)
older than 17 years of age

Intervention dates

October to December 1979

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”A prospective study of topical
TAC and lidocaine infiltration was taken
with the last digit of the patients military
sponsor’s social security number used as the
selection variable, odd numbered patients
were anaesthetised with topical TAC; even
numbered patients were anaesthetised with
lidocaine“
Comment: probably not done

Allocation concealment (selection bias)

High risk

Quote: ”the last digit of the patient’s military sponsor’s social security number used
as the selection variable“
Comment: probably not done. Anaesthetic
agents visually different, and no mention of
safeguards to prevent concealment of identity

Blinding (performance bias and detection High risk
bias)
All outcomes

Quote: none
Comment: probably not blinded, as the paper did not state whether participants or
clinicians were blinded between topical and
infiltrated anaesthetics

Incomplete outcome data (attrition bias)
All outcomes

Low risk

A total of 158 participants enrolled with no
drop-outs or exclusions

selective reporting of outcomes
All outcomes

High risk

All outcomes described in Methods section
were reported in Results, but method of
assessing anaesthetic adequacy appears inconsistent between Methods and Results
sections
Subgroup analysis by age was described in
Methods, but results were not presented for
all subgroups for each outcome
Wound complications were measured at 3
time points, but results were presented only

Topical anaesthetics for pain control during repair of dermal laceration (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

54

Pryor 1980

(Continued)
for overall rate. No adverse events due to
anaesthetic administration were reported
Some results are presented only graphically.

Other bias (sample size)

Unclear risk

82 received topical TAC and 76 received
lidocaine infiltration for anaesthesia

Resch 1998
Methods

Single-centre RCT, emergency department, University of Minnesota-affiliated Children’s
Hospital, Minneapolis, Minnesota, United States

Participants

194 paediatric patients with lacerations of the face and scalp

Interventions

1. Topical LAT solution (lidocaine 4%, epinephrine 1:2000, tetracaine 0.5%), applied
for 20 minutes (n = 103)
2. Topical LAT gel (lidocaine 4%, epinephrine 1:2000, tetracaine 0.5%), applied for 20
minutes (n = 91)

Outcomes

1. The physician assessed the adequacy of initial anaesthesia by probing the wound with
a 27-gauge needle. If any pain was elicited with probing, the anaesthetic was considered
’inadequate’ and infiltrated lidocaine was given.
2. At the conclusion of laceration repair, the physician rated anaesthetic effectiveness
(complete, partial or incomplete) based on painful responses during suturing.
3. The study reported acute adverse reactions directly related to the anaesthetic
Results include the following.
1. Adequacy of initial anaesthesia (adequate anaesthesia: LET solution = 84% vs LET
gel = 82%; P > 0.05)
2. Effectiveness of anaesthesia (complete anaesthesia: LET solution = 76% vs LET gel =
85%; P = 0.007)
3. No acute anaesthetic-related adverse effects

Intervention dates

March 1995 to March 1996

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
Bias

Authors’ judgement

Random sequence generation (selection Low risk
bias)
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(Continued)

Allocation concealment (selection bias)

Low risk

Quote: :hospital pharmacy personnel to label standard amber vials from 1 to 200”
“it was required that the study medication
be applied by a nurse not involved in the
suturing”
Comment: probably done

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: “To ensure blinding of suture personnel, in the trial, it was required that the
study medication be applied by a nurse not
involved in the suturing”
Comment: probably done

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

200 participants enrolled and 3 withdrawn
before test of initial anaesthesia because
participants were unco-operative or complicated laceration did not meet inclusion
criteria. Of the 197 available for analysis, 3
data sheets were inadvertently lost
We concluded low risk of bias because plausible effect size among missing outcomes
was not enough to have a clinically relevant
impact on observed effect size

selective reporting of outcomes
All outcomes

Unclear risk

All prespecified primary and secondary
outcomes were reported: physician determination of adequacy of anaesthetic before
repair and anaesthetic effectiveness during
repair. Adverse effects also reported
Quote: “Pain assessment was a 2-stage process that evaluated adequacy of anaesthesia
before suturing and effectiveness of anaesthesia during suturing”
“Effectiveness of anaesthesia during suturing was divided into 3 categories: complete,
partial, and incomplete”
“Complications assessed were redness,
drainage, fever, tenderness, swelling, or
contact with medical personnel for woundrelated issues other than suture removal”
Quote: “Of the 194 patients, 162 (83.
5%) obtained adequate anaesthesia as determined by the 27-gague needle test”
Table 3. Efficacy of LET solution versus
LET gel for topical anaesthesia of face and
scalp (includes information on complete,
partial and Incomplete effectiveness)
Complications: “No adverse effects were
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(Continued)
noted in the 194 patients during the procedure. 13 patients who were not able to be
contacted… one patient in each study arm
sought medical care for a wound infection“

Other bias (sample size)

Unclear risk

Quote: “LET solution = 103 subjects, LET
gel = 91 subjects”

Schaffer 1985
Methods

Single-centre RCT, Spokane Minor Emergency Centers, Spokane, Washington, United
States

Participants

107 paediatric patients 10 years of age or younger, with laceration on the face (n = 84)
or scalp (n = 23)

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for 10 minutes (n = 56)
2. Topical TA solution (tetracaine 0.5%, epinephrine 1:2000), applied for 10 minutes
(n = 51)

Outcomes

1. The physician rated anaesthetic effectiveness (complete, partial or inadequate) according to the ability of the participant to tolerate manipulation of the wound during repair.
The anaesthesia was ’complete’ if the participant did not cry, complain or wince during
suturing. The anaesthesia was ’partial’ if the participant had some discomfort but did
have an avoidance reaction. ’Inadequate’ anaesthesia was defined as obvious discomfort
with minimal manipulation of the wound.
2. Rescue lidocaine infiltration was required.
3. The study reported any acute adverse reactions to the anaesthetic
Results include the following.
1. Physician rating (complete, partial or inadequate) of anaesthetic effectiveness (complete anaesthesia: topical TA = 47.1% vs topical TAC = 75%; P < 0.05)
2. Requirement of rescue lidocaine infiltration (topical TA = 27.5% vs topical TAC = 8.
9%; P = 0.01)
3. No acute anaesthetic-related adverse effects. However, after returning home from the
emergency department, 10.7% of children treated with TAC and 7.8% who received
topical AC became drowsy or excitable. No evidence suggested that symptoms were
causally related to the topical anaesthetic, and the study author concluded that these
were not anaesthetic-induced adverse effects

Intervention dates

January to July 1983

Declaration of interest

Not reported

Notes

Funding not reported

Risk of bias
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Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”Patients who received topical
anaesthesia were randomized by alternating
between A and B solutions“
Comment: probably not done

Allocation concealment (selection bias)

Quote: ”...randomized by alternating between A and B solutions“
Comment: probably not done

High risk

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”Neither patients nor treating
physicians were informed of the composition of the anaesthetic solutions“
Comment: probably done, assuming topical TAC and TA were visually identical

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

107 participants included in study but reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were
reported: Treating physician rated anaesthetic effectiveness on the basis of participant tolerance of manipulation of wound
during suturing (complete, partial, inadequate)
The only prespecified secondary outcome
was wound infection, which was reported
Quote: “The relative effectiveness of anaesthesia was assessed subjectively by treating
physician based on ability of patient to tolerate manipulation of would during repair”
Table 1. Anesthesia effectiveness (treatment)
Table 2. Wound location (initial examination)
Table 3. Signs of wound infection (followup visits)

Other bias (sample size)

Unclear risk

Quote: “Topical TAC = 56 patients, topical
TA = 51 patients”
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Schilling 1995
Methods

Single-centre RCT, emergency department of a university-affiliated private children’s
hospital, United States

Participants

151 patients, age 1 to 17 years, with facial (69.6%) and scalp (30.4%) lacerations

Interventions

1. Topical TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied
for 15 minutes (n = 73)
2. Topical LET solution (lidocaine 4%, epinephrine 0.1%, tetracaine 0.5%), applied for
15 minutes (n = 78)

Outcomes

1. The physician assessed the adequacy of initial anaesthesia by probing the wound with
a 27-gauge needle.
2. After laceration repair, the physician rated anaesthetic effectiveness (complete, partial
or incomplete). Anaesthesia was ’complete’ if the participant did not have a painful
response to suturing. Anaesthesia was ’partial’ if the participant had a painful response
to suturing, between 15 and 30 minutes after removal of topical solution. Anaesthesia
was considered ’incomplete’ if the participant had a painful response within 15 minutes
after removal of the topical agent.
3. Investigators reported any acute adverse reactions directly related to the anaesthetic
Results include the following.
1. Adequacy of initial anaesthesia (topical LET = 74.4% vs topical TAC = 79.5%; P =
0.46)
2. Physician-rated anaesthetic effectiveness (complete, partial, incomplete) (complete
anaesthesia: topical LAT = 82.4% vs topical TAC = 75.9%; P = 0.18)
3. No acute anaesthetic-related adverse effects

Intervention dates

June 1992 to May 1993

Declaration of interest

Not reported

Notes

Source of funding: financial support provided by the FA Bean Education and Research
Fund, Minneapolis Children’s Medical Center

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”...vials of the anaesthetic solutions
were assigned random numbers..“
Comment: unclear, as study was reported
to be randomized, but method of sequence
generation was not described

Allocation concealment (selection bias)

Quote: ”Both TAC and LET solutions are
aqueous and have the same blue tint and
viscosity“
”labelled to ensure appropriate blindness of
suture personnel“
”A double blind topical application using

Low risk
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3ml of the test solutions was performed [at]
study entry“
Comment: probably done

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”Both TAC and LET solutions
are aqueous and have the same blue tint
and viscosity. Unit-dose, amber vials of the
anaesthetic solutions were assigned random
numbers; labelled to ensure appropriate
blindness of suture personnel; and stored
under refrigeration in the ED. A double
blind topical application using 3ml of the
test solutions was performed [at] study entry“
Comment: probably done

Incomplete outcome data (attrition bias)
All outcomes

Low risk

171 participants were initially enrolled,
but data analysis was performed for only
151 participants. Five participants were excluded after consent was obtained (1 sedated before anaesthetic administration, 2
topical anaesthetics applied for inappropriate duration, 2 data sheets lost). 15 additional participants were withdrawn before
evaluation of anaesthetic effectiveness because participants were unco-operative or
because it was discovered that the wound
involved deeper tissue layers than inclusion
criteria permitted. We concluded low risk
of bias because reasons for exclusion were
unlikely to be related to pain scores during
laceration repair

selective reporting of outcomes
All outcomes

Unclear risk

All outcomes described in Methods were
fully reported in Results section, but subgroup analyses (area of face, age of participant) were not prespecified. Adverse events
were reported

Other bias (sample size)

Unclear risk

73 participants were treated with TAC; 78
participants received LET
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Smith 1996
Methods

Single-centre RCT, emergency department, Children’s Hospital, Columbus, Ohio,
United States

Participants

240 patients, 2 to 17 years old, with lacerations ≤ 5 cm
located on the face (n = 134), scalp (n = 57) or extremity (n = 49)

Interventions

1. Bupivanor (BN) solution (0.48% bupivacaine with 1:26,000 norepinephrine), applied
for 20 minutes (n = 30)
2. Etidonor (EN) solution (0.95% etidocaine with 1:26,000 norepinephrine), applied
for 20 minutes (n = 30)
3. Mepivanor (MN) solution (1.90% mepivacaine with 1:26,000 norepinephrine), applied for 20 minutes (n = 30)
4. Prilonor (PN) solution (3.81% prilocaine with 1:26,000 norepinephrine), applied for
20 minutes (n = 30)
5. TAC solution (tetracaine 1.00%, epinephrine 1:4000, cocaine 4.0%), applied for 20
minutes (n = 60)
6. Infiltrated lidocaine 1% (n = 60)

Outcomes

1. Participants 5 years of age or older, with reported discomfort on the VAS (100 mm)
pain scale
2. Observer-reported VAS (100 mm) pain scale scores (suture technicians and research
assistants)
3. Observer-reported Likert (1-7) pain scale scores (parents and suture technicians).
4. Observer-rated (RICDRS) Restrained Infants and Children Disress Rating Scale (08) (research assistant and suture technician)
5. Suture technician-rated anaesthetic effectiveness scale
Results (topical BN vs topical EN vs topical MN vs topical PN vs topical TAC vs
infiltrated local anaesthetic) include the following.
(standard deviations not reported for any outcomes)
1. Participant-reported VAS (100 mm) pain scores (mean scores: topical BN = 18.3 vs
topical EN = 46.5 vs topical MN = 27.0 vs topical PN = 36.0 vs topical TAC = 12.0 vs
infiltrated local anaesthetic = 26.3) (TAC significantly outperformed EN; P < 0.05; no
significant differences between any other groups)
2a. Suture technician-reported VAS (100 mm) pain scores (mean scores: topical BN =
2.0 vs topical EN =6.3 vs topical MN = 4.8 vs topical PN = 6.2 vs topical TAC = 2.8
vs infiltrated local anaesthetic = 2.0 (EN significantly outperformed by BN, TAC and
infiltrated anaesthetic; P < 0.05; no significant differences between any other groups)
2b. Research assistant-reported VAS (100 mm) pain scores (mean scores: topical BN
=3.3 vs topical EN =7.7 vs topical MN = 4.9 vs topical PN = 8.9 vs topical TAC =
2.9 vs infiltrated local anaesthetic = 1.9) (TAC outperformed both EN and PN; P <
0.05; infiltrated anaesthetic outperformed both EN and PN; P < 0.05; no significant
differences between any other groups)
3a. Suture technician-reported Likert (1-7) pain scores (mean scores: topical BN = 2.
05 vs topical EN = 2.6 vs topical MN = 2.4 vs topical PN = 2.1 vs topical TAC = 1.
55 vs infiltrated local anaesthetic = 1.6 (TAC outperformed both EN and MN; P < 0.
05; infiltrated anaesthetic outperformed both EN and MN; P < 0.05; no significant
differences between any other groups)
3b. Parent-reported Likert (1-7) pain scores (mean scores: topical BN = 2.8 vs topical
EN = 3.5 vs topical MN = 3.3 vs topical PN = 3.6 vs topical TAC = 2.11 vs infiltrated
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local anaesthetic = 2.33 (TAC outperformed EN, MN and PN; P < 0.05; infiltrated
anaesthetic outperformed EN and PN; P < 0.05; no significant differences between any
other groups)
4a. Suture technician-reported RICDRS (0-8) (mean scores: topical BN = 2.5 vs topical
EN = 3.6 vs topical MN = 2.3 vs topical PN = 2.5 vs topical TAC = 1.4 vs infiltrated
local anaesthetic = 1.63 (TAC outperformed EN; P < 0.05; infiltrated anaesthetic outperformed EN; P < 0.05; no significant differences between any other groups)
4b. Research assistant-reported RICDRS (0-8) (mean scores: topical BN = 2.4 vs topical
EN = 3.1 vs topical MN = 2.7 vs topical PN = 2.9 vs topical TAC = 1.6 vs infiltrated local
anaesthetic = 1.8 (TAC outperformed both EN and PN; P < 0.05; infiltrated anaesthetic
outperformed EN; P < 0.05; no significant differences between any other groups)
5. Anaesthetic effectiveness scale (scores not reported) (TAC outperformed EN and MN;
P < 0.05; infiltrated anaesthetic outperformed BN, EN, MN, PN; P < 0.05; no significant
differences between any other groups)

Intervention dates

July to December 1992

Declaration of interest

No explicit documentation regarding conflicts of interest

Notes

Source of funding: Ohio State University Seed Grant Program, Bremer Research Foundation, Ohio State University and Samuel J. Roessler Memorial Scholarship Fund
Study author contacted to request additional study data; study author replied but unable
to provide the missing information. High risk of bias for local anaesthetic vs topical
anaesthetic, as this comparison was not blinded. However,unclear risk of bias in 3 domains for comparisons of different topical anaesthetics because of appropriate blinding

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”Study patients were assigned to
one of six anaesthetic treatment groups using block randomization“
Comment: unclear, as exact method of selecting the blocks was not reported

Allocation concealment (selection bias)

Comment: unclear

Unclear risk

Blinding (performance bias and detection Low risk
bias)
All outcomes
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Quote: ”Comparisons among the five topical preparations were double blinded. Because lidocaine was given as an injection,
its identity was not blinded“; ”Anesthetics were prepared in advance by Children’s
Hospital pharmacy, sealed in envelopes labelled with a study identification number,
and stored in a locked cabinet in the emergency department“
Comment: probably blinded between
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comparisons of different topical agents, but
probably not blinded between comparisons
of infiltrated lidocaine and topical anaesthetic

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

240 participants included in the study but
reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported in the prespecified way

Other bias (sample size)

Unclear risk

240 participants enrolled:
1. Bupivanor (BN) solution, n = 30
2. Etidonor (EN) solution, n = 30
3. Mepivanor (MN), n = 30
4. Prilonor (PN) solution, n = 30
5. TAC solution, n = 60
6. Infiltrated lidocaine, n = 60

Smith 1997a
Methods

Single-centre RCT, emergency department or a large children’s hospital, United States

Participants

71 patients, 2-16 years old, with lacerations ≤ 5 cm in length located on the face (n =
43) or scalp (n = 28)

Interventions

1. Mepivanor (MN) solution (mepivacaine 2%, norepinephrine 1:100,000), applied for
20 minutes (n = 24)
2. TAC solution (tetracaine 1.0%, epinephrine 1:4000, cocaine 4.0%), applied for 20
minutes (n = 24)
3. Intradermal infiltration with lidocaine 1% (n = 23)

Outcomes

1. Observer-reported VAS (100 mm) pain scale scores (suture technicians, research assistants and videotape reviewers)
2. Observer-reported Lickert (1-7) pain scale scores (parents, suture technicians)
3. Requirement for supplemental lidocaine infiltration
Results (topical MN vs topical TAC vs infiltrated local anaesthetic) include the following.
1a. Suture technician-reported VAS (100 mm) pain scores (mean score ± SD: topical
MN = 7.1 ± 12.5 vs topical TAC = 2.0 ± 2.7 vs infiltrated anaesthetic = 1.8 ± 4.0) (Both
topical TAC and infiltrated anaesthetic outperformed topical MN; P = 0.003.)
1b. Research assistant-reported VAS (100 mm) pain scores (mean score ± SD: topical
MN = 14.8 ± 19.5 vs topical TAC = 4.7 ± 8.5 vs infiltrated anaesthetic = 3.0 ± 4.0).
(Both topical TAC and infiltrated anaesthetic outperformed topical MN; P = 0.0003.)
1c. Videotape reviewer-reported VAS (100 mm) pain scores (mean score ± SD: topical
MN = 5.0 ± 12.5 vs topical TAC = 5.25 ± 16.42 vs infiltrated anaesthetic = 2.0 ± 5.9)
(no reported differences between groups; P > 0.05)
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2a. Suture technician-reported Likert (1-7) pain scores (mean score ± SD: topical MN =
2.2 ± 1.4 vs topical TAC = 1.7 ± 0.9 vs infiltrated anaesthetic = 1.6 ± 1.0) (no reported
differences between groups; P = 0.18)
2b. Parent-reported Likert (1-7) pain scores (mean score ± SD: topical MN = 3.7 ± 1.9
vs topical TAC = 2.4 ± 1.8 vs infiltrated anaesthetic = 2.4 ± 1.6) (Both topical TAC and
infiltrated anaesthetic outperformed topical MN; P = 0.02.)
3. Requirement for supplemental lidocaine infiltration (topical MN = 37.5% vs topical
TAC = 8.3%; P = 0.04)

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Source of funding: Support was provided by a grant from the Children’s Hopsital Research
Foundation, Columbus, Ohio (Grant #020-876)
Obtained additional study data by directly contacting study author

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”Enrolled patients were assigned to
receive one of three anaesthetic preparations by block randomization“
Comment: unclear, as exact method of selecting the blocks not described in the study

Allocation concealment (selection bias)

Comment: unclear

Unclear risk

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: ”Comparions between topical
Mepivanor and TAC were blinded to all observers. Since lidocaine was given as an injection, its identity was not blinded to those
present for the procedure. However, after
the anaesthetic was administered, suturing
procedures were videotaped. These videotapes were later reviewed by an observer
who was completely blinded to which local
anaesthetic the patient had received“
Comment: probably done

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

71 participants included in the study but
reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were reported: observer-reported VAS pain score
by suture technicians, research assistants ascertained at the end of the suturing proce-
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dure. Also, Lickert pain scale scores (participant, suture technician)
Prespecified secondary outcomes were also
reported: pain during application of anaesthesia and requirement for supplemental lidocaine infiltration
Quote: “Pain perceptions of suture technicians, research assistants were ascertained
at the end of the suturing procedure by
means of the visual analogue scale (VAS)
… Pain perceptions of the parents and suture technicians were also measured using
a seven-point Likert scale…Observers were
instructed to base their pain scores on the
pain experienced as the needle pierced the
skin in order to measure actual anaesthetic
performance”
Figure 1. Mean VAS pain score by anaesthetic treatment group for suture
technicians compared with research assistants compared with videotape reviewer
Figure 2. Mean Likert scale to rate the
amount of pain they thought the child experienced during suturing by each anaesthetic treatment group for suture technicians compared with parents for all laceration types of repair
Additional reporting:
“Suture technicians were instructed to give
additional lidocaine by infiltration.. if they
felt that the child had inadequate wound
anaesthesia. Two patients received lidocaine rescue in the TAC group compared
to 9 patients in the Mepivanor group”
“..Sixty six patients returned within 48
hours for a wound check. All wounds were
healing without complication at that time,
except for one patient…. There was one
additional complication reported at the 2week follow up for a patient”

Other bias (sample size)

High risk
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Methods

Single-centre RCT, emergency department, Children’s Hospital, Columbus, Ohio,
United States

Participants

240 patients, 1 to 18 years of age, with lacerations ≤ 5 cm in length, located on the face
(51%), scalp (30%), extremity (18%) or other site (1%)

Interventions

1. Prilophen (PP) solution (prilocaine 3.56%, phenylephrine 0.99%), applied for 20
minutes (n = 60)
2. Tetraphen (TP) solution (tetracaine 1.0%, phenylephrine 5.0%), applied for 20 minutes (n = 60)
3. Tetralidophen (TLP) solution (tetracaine 1.0%, lidocaine 1.0%, phenylephrine 2.
5%), applied for 20 minutes (n = 60)
4. TAC solution (tetracaine 1.0%, epinephrine 1:4000, cocaine 4.0%), applied for 20
minutes (n = 60)

Outcomes

1. Participants 5 years of age or older reported VAS (100 mm) pain scale scores.
2. Observer-reported VAS (100 mm) pain scale scores (suture technicians, research assistants and parents)
3. Observer-reported Likert (1-7) pain scale scores (suture technicians, research assistants
and parents)
4. Suture technicians rated anaesthetic effectiveness (complete, partial or no anaesthesia)
Results (topical PP vs topical TP vs topical TLP vs topical TAC) include the following.
1. Participant self-reported VAS (100 mm) pain scores (mean score ± SD: topical PP =
29.0 ± 43.4 vs topical TP = 24.2 ± 37.2 vs
topical TLP = 30.6 ± 40.3 vs topical TAC = 17.6 ± 34.1) (no reported differences between
groups; P = 0.5)
2a. Suture technician-rated VAS (100 mm) pain scores (mean score ± SD: topical PP =
7.4 ± 16.0 vs topical TP = 5.1 ± 12.6 vs
topical TLP = 6.0 ± 13.5 vs topical TAC = 3.5 ± 11.8) (Topical TAC performed significantly better then topical PP; reported P = 0.04.)
2b. Research assistant-rated VAS (100 mm) pain scores (mean score ± SD: topical PP =
1.6 ± 2.6 vs topical TP = 1.9 ± 4.2 vs
topical TLP = 1.3 ± 1.7 vs topical TAC = 0.9 ± 1.7) (no reported differences between
groups; P = 0.09)
2c. Parent-rated VAS (100 mm) pain scores (mean score ± SD: topical PP = 20.0 ± 21.
7 vs topical TP = 20.2 ± 21.7 vs
topical TLP = 18.2 ± 18.6 vs topical TAC = 14.0 ± 18.6) (no reported differences between
groups; P = 0.09)
3a. Suture technician-reported Likert (1-7) pain scores (median score: topical PP = 2.0
vs topical TP = 1.0 vs topical TLP = 2.0 vs topical TAC = 1.0) (Topical TAC performed
significantly better than topical PP or topical TLP; P = 0.01.)
3b. Research assistant-reported Likert (1-7) pain scores (median score: topical PP = 2.0
vs topical TP = 1.0 vs topical TLP = 2.0 vs topical TAC = 1.0) (Topical TAC performed
significantly better than topical PP or topical TLP; P = 0.03.)
3c. Parent-reported Likert (1-7) pain scores (median score: topical PP = 2.0 vs topical
TP = 2.0 vs topical TLP = 2.0 vs topical TAC = 2.0) (mo reported differences between
any of the groups; P = 0.06)
4. Anaesthetic effectiveness (complete anaesthesia: topical PP = 63% vs topical TP =
67% vs topical TLP = 65% vs topical TAC = 80%) (mo reported differences between
any of the groups; P =.18)
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Intervention dates

June to September 1994

Declaration of interest

No explicit documentation regarding conflicts of interest

Notes

Source of funding: Grant 020-898 from Children’s Hospital Research Foundation and
Samuel J. Roessler Memorial Scholarship Fund
Study author contacted to request additional study data; study author replied but unable
to provide missing information

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Unclear risk
bias)

Quote: ”Patients were randomly assigned
to one of four anaesthetic treatment groups.
.“
Comment: unclear, as study was reported
to be randomized but method of sequence
generation was not described

Allocation concealment (selection bias)

Comment: unclear

Unclear risk

Blinding (performance bias and detection Unclear risk
bias)
All outcomes

Quote: ”using a prospective, randomized,
double-blind design...“
”Anesthetic agents were sealed in envelopes
labelled with a study identification number
and stored in a locked cabinet in the emergency department“
Comment: probably done, assuming topical solutions visually identical

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

240 participants included in the study but
reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported in the prespecified way

Other bias (sample size)

Unclear risk

240 children enrolled:
1. Prilophen (PP) solution, n = 60
2. Tetraphen (TP) solution, n = 60
3. Tetralidophen (TLP) solution, n = 60
4. TAC solution, n = 60
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Methods

Single-centre RCT, emergency department or a large children’s hospital, United States

Participants

180 patients, 1 to 18 years old, with lacerations ≤ 5 cm, located on the face (n = 76),
scalp (n = 59), extremity (n = 43) or other (n = 2)

Interventions

1. Prilophen (PP) solution (3.56% prilocaine, 0.10% phenylephrine), applied for 20
minutes (n = 60)
2. Bupivaphen (BP) solution (0.67% bupivacaine, 0.10% phenylephrine), applied for
20 minutes (n = 60)
3. TAC solution (tetracaine 1.0%, epinephrine 1:4000, cocaine 4.0%), applied for 20
minutes (n = 60)

Outcomes

1. Participants 5 years of age and older self-reported pain using a VAS (100 mm) scale.
2. Observer-reported VAS (100 mm) pain scale scores (suture technicians, research assistants and parents)
Results (topical PP vs topical BP vs topical TAC) included the following.
1. Participant self-reported VAS (100 mm) pain scores (mean score ± SD: topical PP =
21.0 ± 28.0 vs topical BP = 41.0 ± 35.0 vs topical TAC = 18.0 ± 24.0) (no differences
reported between groups; P = 0.07)
2a. Suture technician-rated VAS (100 mm) pain scores (mean score ± SD: topical PP = 3.
8 ± 8.5 vs topical BP = 5.0 ± 9.0 vs topical TAC = 1.5 ± 3.0) (Topical TAC outperformed
topical BP; P = 0.006; no differences between TAC and PP; no differences between BP
and PP)
2b. Research assistant-rated VAS (100 mm) pain scores (mean score ± SD: topical PP = 3.
0 ± 6.0 vs topical BP = 3.8 ± 4.9 vs topical TAC = 1.4 ± 2.1) (Topical TAC outperformed
topical BP; P = 0.002; no differences between TAC and PP; no differences between BP
and PP)
2c. Parent-rated VAS (100 mm) pain scores (mean score ± SD: topical PP = 24.0 ± 24.
5 vs topical BP = 29.0 ± 28.0 vs topical TAC = 17.0 ± 20.5) (TAC outperformed BP; P
= 0.03; no differences between TAC and PP; no differences between BP and PP)

Intervention dates

Not reported

Declaration of interest

Not reported

Notes

Funding source: supported by Grant 020-898 from the Children’s Hospital Research
Foundation, Columbus, Ohio. Stipend support for medical students was provided by
the Samuel L. Roessler Memorial Medical Scholarship Fund
Study author contacted to request additional study data; study author replied but unable
to provide missing information

Risk of bias
Bias

Authors’ judgement

Random sequence generation (selection Unclear risk
bias)
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using block randomization”
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lecting the blocks not reported

Allocation concealment (selection bias)

Unclear risk

Comment: unclear

Blinding (performance bias and detection Unclear risk
bias)
All outcomes

Quote: “using a prospective, randomized,
double-blind design...”
“Anesthetics were sealed in envelopes labelled with a study identification number
and stored in a locked cabinet in the ED”
Comment: probably done, assuming solutions visually identical

Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

180 participants included in the study but
reporting of attrition or exclusions insufficient to permit judgement

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary and secondary
outcomes were reported: VAS pain scores
during suturing by participants and observers (suture technicians, research assistants, parents)
Quote: “Pain perceptions of suture technicians, research assistants, parents and patients 5 years of age and older were ascertained using a visual analogue scale (VAS)
… Observers based pain scores on the pain
experienced as the needle pierced the skin
in order to measure actual anaesthetic performance”
Figure 1. Mean VAS pain score by anaesthetic treatment group for suture
technicians compared with research assistants for all types of laceration of repair
Figure 2. Mean VAS pain score by anaesthetic treatment group for participants
compared with parents for all types of laceration repair
Figure 3. Mean VAS pain score by anaesthetic treatment group for suture technicians compared with research assistants for
only face and scalp laceration repairs
Figure 4. Mean VAS pain score by anaesthetic treatment group for participants
compared with parents for face and scalp
lacerations only
Additional reporting:
1. Complications at follow-up were listed
as “2 wound infections, 1 case of wound
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drainage that resolved without antibiotics,
3 cases of lost stitches, and 3 cases of wound
dehiscence”

Other bias (sample size)

Unclear risk

Quote: “Participants were 180 children.
Three groups each of 60 subjects each: TAC
vs Prilophen vs Bupivaphen“

Vinci 1996
Methods

Single-centre RCT, urban paediatric emergency department, Boston, Massachusetts,
United States

Participants

156 patients, 3 to 18 years old, with lacerations on the face/scalp (n = 102), extremity
(n = 47) or trunk (n = 7)

Interventions

1. TAC 1 solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 11.8%), applied for
15 to 30 minutes (n = 49)
2. TAC 2 solution (tetracaine 1.0%, epinephrine 1:2000, cocaine 4.0%), applied for 15
to 30 minutes (n = 49)
3. TAC 3 solution (tetracaine 1.0%, cocaine 4.0%), applied for 15 to 30 minutes (n =
58)

Outcomes

1. Physician rating of anaesthetic effectiveness (complete, partial or no anaesthesia).
Anaesthesia was ’complete’ if the participant did not move, flinch or grimace during
repair. Anaesthesia was ’partial’ if the participant complained of pain, moved or grimaced.
If supplemental lidocaine infiltration was required, then ’no anaesthesia’ was given.
2. Requirement for a second application of topical anaesthetic
3. Requirement for supplemental lidocaine infiltration
4. The study reported acute adverse effects directly due to the anaesthetic
Results for TAC 1 (standard formulation) vs TAC 3 (tetracaine-cocaine) include the
following.
1. Incidence of complete anaesthesia (topical TAC 1 = 73% vs topical TAC 3 = 28%; P
< 0.001)
2. Requirement for a second dose of topical anaesthetic (topical TAC 1 = 30% vs topical
TAC 3 = 66%; P < 0.003)
3. Requirement for supplemental lidocaine infiltration (topical TAC 1 = 6% vs topical
TAC 3 = 9%; P = not reported)
Results for TAC 2 (higher concentration tetracaine, lower concentration cocaine) vs TAC
3 (tetracaine-cocaine) include the following.
1. Incidence of complete anaesthesia (topical TAC 2 = 63% vs topical TAC 3 = 28%; P
< 0.001)
2. Requirement for a second dose of topical anaesthetic (topical TAC 2 = 46% vs topical
TAC 3 = 66%; P < 0.003)
3. Requirement for supplemental lidocaine infiltration (topical TAC 2 = 2% vs topical
TAC 3 = 9%; P = not reported)
4. A single paediatric participant developed an erythematous rash 1 day after application
of standard topical TAC
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Intervention dates

Not reported

Declaration of interest

No explicit documentation regarding conflicts of interest

Notes

Source of funding: not reported

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Low risk
bias)

Quote: ”The solutions were batched in lots
of 10 doses to limit expiration of the study
drugs. The order of batching was generated
using a standard table of random numbers“
Comment: probably done

Allocation concealment (selection bias)

Quote: ”The order of batching was generated using a standard table of random numbers“
Comment: probably not done

High risk

Blinding (performance bias and detection Unclear risk
bias)
All outcomes

Quote: ”...we conducted a randomized,
prospective, double-blind, clinical trial
comparing three different formulations of
cocaine-containing topical anaesthetics“
Unclear: In the Introduction section, reported to be a double-blind study, but no
details provided in Methods or any other
sections

Incomplete outcome data (attrition bias)
All outcomes

Low risk

A total of 165 participants were randomized in the study, and no missing outcome
data or exclusions

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported in the prespecified way

Other bias (sample size)

High risk

165 participants:
1. TAC 1 solution, n = 49
2. TAC 2 solution, n = 49
3. TAC 3 solution, n = 58
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Methods

Single-centre RCT, emergency department at Arizona Health Sciences Center, Arizona,
United States

Participants

68 adult patients, older than 18 years of age, with lacerations < 5 cm in length, located
on the face (n = 22) or non-facial (n = 46)

Interventions

1. TAC solution (tetracaine 0.5%, epinephrine 1:2000, cocaine 10.0%), applied for 5
to 10 minutes (n = 36)
2. Tetracaine solution (tetracaine 0.5%), applied for 5 to 10 minutes (n = 32)

Outcomes

1. Participant-rated numerical pain scale score (0-10)
2. Requirement of supplemental lidocaine infiltration
Results include the following.
1. Participant-rated numerical pain scale (0-10) score (mean pain scores: topical tetracaine
= 5.6 vs topical TAC = 3.53; P < 0.05; standard deviations not reported)
2. Requirement for rescue lidocaine infiltration (topical tetracaine = 59% vs topical TAC
= 36%; P = not reported)

Intervention dates

Not reported

Declaration of interest

No explicit documentation regarding conflicts of interest

Notes

Source of funding: not reported

Risk of bias
Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection High risk
bias)

Quote: ”Prior to delivery to the emergency
department, the TAC and tetracaine solutions were assigned odd or even numbers“;
”Randomization was achieved by matching
the vials to the odd or even numbers at the
end of the hospital number“
Comment: probably not done

Allocation concealment (selection bias)

Quote: ”Randomization was achieved by
matching the vials to the odd or even numbers at the end of the hospital number“
Comment: probably not done

High risk

Blinding (performance bias and detection Low risk
bias)
All outcomes
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Incomplete outcome data (attrition bias)
All outcomes

Unclear risk

68 patients participated in the study. It is
not clear whether the same number were
randomized, or whether any were withdrawn

selective reporting of outcomes
All outcomes

Low risk

The study protocol is available, and all of
the study’s prespecified outcomes have been
reported in the prespecified way

Other bias (sample size)

High risk

Total N = 68:
1. TAC solution, n = 36
2. Tetracaine solution, n = 32

Zempsky 1997
Methods

Single-centre RCT, emergency department of Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States

Participants

32 patients, 5 to 18 years old, with lacerations < 5 cm long, located on the extremity (n
= 32)

Interventions

1. EMLA cream (lidocaine 2.5%, prilocaine 2.5%), applied for maximum of 60 minutes
(n = 16)
2. TAC solution (formulation not reported by study), applied for maximum of 30
minutes (n = 16)

Outcomes

1. Participant-rated VAS (100 mm) pain scores
2. Observer-rated VAS (100 mm) pain scores by suturing physician and parent
3. Requirement for supplemental lidocaine infiltration
Results included the following.
1. Participant-rated VAS (100 mm) pain scores (mean score ± SD: EMLA = 46.0 ± 26.
0 vs topical TAC = 40.0 ± 25.0; P = 0.50)
2. Parent-rated VAS (100 mm) pain scores (mean score ± SD: EMLA = 42.0 ± 15.0 vs
topical TAC = 43.0 ± 25.0; P = 1.0) and physician-rated VAS (100 mm) pain scores
(mean score ± SD: EMLA = 30.0 ± 16.0 vs topical TAC = 26.0 ± 14.0; P = 0.45)
3. Requirement for supplemental lidocaine infiltration (EMLA = 15% vs topical TAC
= 55%; P = 0.03)

Intervention dates

April to December 1994

Declaration of interest

Not reported

Notes

Funding source: supported by Grant 5M01 RR00084 from the General Clinical Research
Center, Children’s Hospital of Pittsburgh

Risk of bias
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Bias

Authors’ judgement

Support for judgement

Random sequence generation (selection Low risk
bias)

Quote: “...the patient was randomized into
one of the two study groups by a table of
random numbers”
Comment: probably done

Allocation concealment (selection bias)

Quote: “...the patient was randomized into
one of the two study groups by a table of
random numbers”
Comment: probably not done

High risk

Blinding (performance bias and detection Low risk
bias)
All outcomes

Quote: “The suturers, who were blinded to
the patients’ assignments, were not investigators in the study and were not allowed
to see the patient until the anaesthetic had
been removed and the wound irrigated”
Comment: probably done

Incomplete outcome data (attrition bias)
All outcomes

Low risk

A total of 32 participants enrolled with no
drop-outs or exclusions

selective reporting of outcomes
All outcomes

Low risk

All prespecified primary outcomes were reported: observer- or participant-reported
VAS pain scores during suturing
One prespecified secondary outcome was
also reported: need for supplemental infiltrated lidocaine
Quote: “Assessment of pain associated with
the entire procedure was conducted independently by the suturing physician, the
patient, and the parent or guardian on the
10-cm visual analogue scale (VAS)”
Table. Pain scores on a 10-cm VAS contains participant, parent and physician VAS
scores
Figure. Efficacy of EMLA and TAC
demonstrates efficacy adequacy of anaesthesia after the procedure began
Additional reporting:
Complications were listed with “one case of
wound dehiscence before suture removal in
each group and no wound infections were
seen in either group“

Other bias (sample size)

High risk

Quote: “a convenience sample of 32 patients were enrolled in our study group:
EMLA cream 16 subjects and TAC solu-
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tion 16 patients”

AC: epinephrine (adrenaline) and cocaine; BN: bupivacaine-noradrenaline; BP:blood pressure; CI: confidence interval; cm: centimetre;
c/w: compared with; ED: emergency department; EMLA: Eutectic Mixture of Local Anesthetics (lidocaine and prilocaine); EN:
etidocaine-noradrenaline; LAT: lidocaine, epinephrine and tetracaine (same as LET); LE: lidocaine and epinephrine; LET: same
as LAT; LG: local gel; LI: local infiltration; MAC: bupivacaine 0.5%, epinephrine 1:2000, cocaine 10.0%; mm: milli-metre;
MN: mepivacaine-noradrenaline; PN: prilocaine-noradrenaline; N: number; NS: not significant; P = P value; PP: prilocaine,
phenylephrine; RCT: randomized controlled trial; RICDRS: Restrained Infants and Children Distress Rating Scale; SD: standard
deviation; SE: standard error; TA: tetracaine and epinephrine; TAC: tetracaine, epinephrine and cocaine; TLE: topical lidocaine
and epinephrine; TLP: tetracaine, lidocaine and phenylephrine; TP; tetracaine and phenylephrine; VAS: visual analogue scale; vs:
versus; w/w: weight per weight.

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Adler 1998

Study compared topical lidocaine-epinephrine-tetracaine (LET) only vs placebo. No comparison with infiltrated
local anaesthetics or other topical anaesthetics

Adriansson 2004

Topical xylocaine was not the primary anaesthetic for repair of the dermal injury. Instead the topical anaesthetic
was only pretreatment given before infiltration with local anaesthetic

Akan 2012

Stimulus was breast surgery, not laceration repair. Also, deep tissue may be involved

Alster 2013

Stimulus was a cosmetic procedure, not dermal laceration repair

Anderson 2012

Review article, not a trial

Bartfield 1995

Topical agent was not the primary anaesthetic for repair of the dermal injury. Topical agent was only pretreatment
given before infiltration with local anaesthetic

Bartfield 1996

Topical agent was not the primary anaesthetic for repair of the dermal injury. Topical agent was only pretreatment
given before infiltration with local anaesthetic

Bass 1990

Not a randomized controlled trial. No controls, and all participants received topical lignocaine-adrenalinecocaine

Beg 2010

Procedure is minimally invasive genealogical procedure, not dermal laceration repair

Bonadio 1988a

Not a randomized controlled trial. No controls, and all participants received topical TAC

Bonadio 1988b

Not a randomized controlled trial. No controls, and all participants received topical TAC

Bonadio 1992

Not a randomized controlled trial. No controls, and all participants received TAC gel

Topical anaesthetics for pain control during repair of dermal laceration (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

75

(Continued)

Bonadio 1996

Study evaluated participants with lacerations located on mucous membranes

Chale 2006

Compared local anaesthetic vs digital anaesthesia. All lacerations were pretreated with topical anaesthetic, but
this was done only to reduce pain from local anaesthetic infiltration. Topical anaesthesia was not used to reduce
pain from repair of lacerations

Chipont 2001

Not a randomized controlled trial. No controls, and all participants received topical LAT

Christensen, 2013

Procedure is wound VAC change, not laceration repair. Also, local anaesthetic was injected into the wound VAC
sponge rather than into the skin

Gyftopoulos 2011

Stimulus was minor surgery on adult penis, not laceration repair

Liebelt 1997

Not a randomized controlled trial. Instead, this is a review article

Little 2004

Outcomes of interest not measured; some lacerations repaired by non-invasive procedures with additional
analgesia/anaesthesia administrated to some participants

Lupo 2010

Not a study on repair of lacerations

Park 2015

Topical anaesthetic was not the primary anaesthetic. Study compares topical local anaesthetics plus infiltration
vs infiltration only

Peirluisi 1989

Not a randomized controlled trial; this is a retrospective study. Also, outcomes were not relevant to this review

Priestley 2003

Outcomes of interest were not measured.

Ridderikhof 2015

Not an RCT

Saariniemi 2013

Intervention was blepharoplasty rather then laceration repair

Singer 2000

Topical anaesthetic was only a pretreatment given before infiltration with local anaesthetic. Also, some wound
closures were performed with adhesives

Singer 2001

Topical anaesthetic was only a pretreatment given before infiltration with local anaesthetic. Also, some wound
closures were performed with adhesives

Smith 1990

Some participants (12) were sedated with chloral hydrate.

Smith 1998b

Study evaluated participants with lacerations located on mucous membranes

Smith 1998c

Study evaluated patients with lacerations located on mucous membranes

Sobanko 2012

This is a review article.

Spillman 2012

This is a review article, not a trial.
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(Continued)

Spivey 1987

Outcomes of interest were not measured.

Stewart 1998

Topical agent was not the primary anaesthetic for repair of the dermal injury. Topical agent was only a pretreatment given before lidocaine infiltration

White 2004

Not a randomized controlled trial. No controls, and all participants received LAT gel

Yamamoto 1997

Not a randomized controlled trial

LAT: lidocaine, adrenaline, and tetracaine; LET: lidocaine-epinephrine-tetracaine; TAC: tetracaine-adrenaline-cocaine; VAC: vacuum.
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